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ABSTRACT: Tetrahydrofurans and pyrrolidines are among the most important heterocycles found in 
bioactive compounds. Cyclization-functionalization domino reactions of alcohols or amines onto olefins 
constitute one of the most efficient methods to access them. In this context, oxy- and aminoalkynylation 
are especially important reactions, due to the numerous transformations possible with the triple bond of 
acetylenes, yet these methods have been limited to the use of silyl protected acetylenes. Herein, we re-
port the first palladium-catalyzed oxy- and aminoalkynylation using aliphatic bromoalkynes, which pro-
ceeded with high diastereoselectivity and functional group tolerance. A one-pot hydrogenation of the 
triple bond gave then access to alkyl-substituted tetrahydrofurans and pyrroldines. Finally, a detailed 
study of the side products formed during the reaction gave a first insight into the reaction mechanism. 
Introduction 
Saturated heterocycles are essential substructures in a large variety of natural and synthetic bioactive 
compounds. Tetrahydrofurans and pyrrolidines substituted with functionalized aliphatic chains on posi-
tions C2 and/or C5 are of particular interest due to their presence in natural products exhibiting signifi-
cant biological and pharmacological activity. Eminent examples include trans-2,5-disubstituted tetrahy-
  
drofurans in antitumoral annonaceous acetogenins, such as gigantecin (1)1 or cis-2,5-disubstituted pyr-
rolidines in antiviral broussonetines, such as broussonetine G (2)2 or in the antifungal preussin (3) (Fig-
ure 1).3 
 
Figure 1. Examples of biologically active natural products containing 2,5-disubstituted tetrahydrofurans 
and pyrrolidines. 
One important approach for the synthesis of functionalized tetrahydrofurans and pyrrolidines relies on 
the Pd-catalyzed cyclization of an oxygen or nitrogen nucleophile onto a tethered alkene followed by 
further C-O, C-C or C-N bond formation.4-6 When considering the large variety of available subsequent 
transformations for the C≡C triple bond, the formation of a sp3-sp bond in this process would be highly 
desirable. This transformation requires the use of an electrophilic acetylene source. Recent years pro-
duced impressive progress in the field of electrophilic alkynylation of aromatic and aliphatic C-H bonds 
using Pd catalysis.7 In these processes, acetylenes bearing bulky silyl groups have been used most often, 
followed by aryl acetylenes. On the other hand, the use of aliphatic acetylenes has been much more lim-
ited. Several reasons concur to make this class of substrates more challenging: The different electronic 
properties change the kinetic of key catalytic steps, especially reductive elimination; the triple bond is 
more accessible for direct reaction with the metal catalyst; finally the presence of hydrogen or function-
al groups at the propargylic position open the way for isomerization side reactions. 
 In 2011, we reported the first example of intramolecular Pd(0)-catalyzed oxy- and amino-alkynylation 
of -hydroxy alkenes using electrophilic bromoacetylenes (Scheme 1).8 These transformations were 
  
complementary to the oxy- and aminoalkynylation methods we previously developed for the synthesis 
of propargyl lactones and lactams under Pd(II)/Pd(IV)-catalysis using the hypervalent iodine reagent 
TIPS-EBX.9 Nevertheless, both methods were limited to the use of silylated alkynyl bromides as elec-
trophiles. This limitation makes the method less attractive for the convergent synthesis of alkyl-
substituted tetrahydrofurans and pyrrolidines after reduction of the triple bond. In principle, similar 
products could be accessed also via an olefin heterovinylation or heteroalkylation approach. However, 
the former has been realized only with unfunctionalized aliphatic substituents on the alkene so far6i,k,l 
and the latter is an unknown process. 
Herein, we would like to report the first successful Pd-catalyzed oxy- and aminoalkynylation of ali-
phatic bromo acetylenes (Scheme 1). The method was successfully applied to both alcohols and N-Boc 
protected amines with high diastereoselectivity. For the first time, we were able to use bromoacetylenes 
bearing functionalized aliphatic chains. The obtained alkynes can be easily reduced to the alkyl chains 
in a practical one-pot process. Finally, a detailed study of the side products formed during oxyalkynyla-
tion allowed us to gain a first insight into the reaction mechanism.  
Scheme 1. Extending the scope of heteroalkynylation to aliphatic alkynes. 
 
Results and Discussion 
Commercially available 4-penten-1-ol (5a) was initially selected as the model substrate to investigate 
the oxyalkynylation with aliphatic bromo acetylenes. A complex mixture had been observed when phe-
nylethyl ethynyl bromide had been used as the alkynylating reagent.8 In order to eliminate any potential 
negative influence of the phenyl group in close proximity to the triple bond, 1-bromooctyne (6a) was 
  
examined in the reaction. Indeed, the desired 2-nonynyl tetrahydrofuran 7aa could be obtained in 44% 
yield using Pd2(dba)3 as palladium source and bis(2-diphenylphosphinophenyl)ether (DPEPHos) as lig-
and (Table 1, entry 1). Starting from this lead result, the influence of the palladium source was further 
evaluated. The use of PdCl2(PPh3)2 (entry 2) or Pd(OAc)2 (entry 3) as precatalysts led to lower yields. A 
significant improvement was observed with N-heterocyclic carbene Pd-complex 8, which gave the 
product in 56% yield in the presence of DPEPHos (entry 4). However, no conversion could be observed 
when the same Pd complex was used in the absence of DPEPHos (entry 5), suggesting that the carbene 
ligand had no influence on the reaction. Similar yields were obtained when the reaction was performed 
with complexes bearing only weakly coordinated ligands, such as [Pd(allyl)(cod)](BF4)2 (entry 6). 
[Pd(cinnamyl)Cp)], a reported clean source of Pd0 for catalysis,10 led to the same result obtained with 
[Pd(allyl)(cod)](BF4)2 (entry 7). The use of Pd(dba)2 also resulted in a slight improvement of the yield 
when compared to Pd2(dba)3 (entry 8). This result raises the question wether enone ligands have a fa-
vorable effect on the reaction. However, when dba was added to [Pd(allyl)(cod)](BF4)2, no increase in 
yield was observed (entry 9). The use of other enone ligands led to a decrease in yield.11 Overall, this 
series of experiments demonstrated that the source of Pd had only a limited influence on the reaction 
outcome. At this point, Pd(dba)2 was identified as the best compromise between price and efficiency for 
the screening of reaction conditions.  
Table 1: Screening of Pd catalysts and alkynyl reagents. 
 
Entry X Catalyst Ligand Yielda 
1 Br (6a) Pd2(dba)3 DPEPHos 44% 
2 Br (6a) PdCl2(PPh3)2 DPEPHos 31% 
  
3 Br (6a) Pd(OAc)2 DPEPHos 30% 
4 Br (6a) NHC-Pd (8)b DPEPHos 56% 
5 Br (6a) NHC-Pd (8)b - 0% 
6 Br (6a) [Pd(allyl)(cod)]BF4 DPEPHos 50% 
7 Br (6a) [Pd(cinnamyl)Cp] DPEPHos 50% 
8 Br (6a) Pd(dba)2 DPEPhos  51% 
9 Br (6a) [Pd(allyl)(cod)]BF4 / dba DPEPHos  47% 
10 Br (6a) Pd(dba)2 DPEPHos 38%
c 
11 Br (6a) Pd(dba)2 XantPhos 29% 
12 Br (6a) Pd(dba)2 dppf 16% 
13 Br (6a) Pd(dba)2 SegPhos 0% 
14 Br (6a) Pd(dba)2 BINAP 0% 
15 Cl (6b) Pd(dba)2 DPEPHos traces 
16 I (6c) Pd(dba)2 DPEPHos 16% 
aReaction conditions: 0.15 mmol 5a, 0.006 mmol catalyst (based on Pd content, 4 mol %), 0.012 
mmol DPEPHos (8 mol %), 0.225 mmol 1-halooct-1-yne 6 (1.5 equiv), 0.225 mmol NaOtBu (1.5 
equiv), 0.8 mL toluene, 3 h, 80 °C, yield was determined by GC-MS; b(NHC)Pd(allyl)Cl (8) = Al-
lyl[1,3-bis(mesityl)imidazol-2-ylidene]palladium chloride; c0.0060 mmol DPEPHos (4 mol %). 
We decided to focus our attention next on the screening of different diphosphines as ligands. DPEPH-
os was optimal for the cyclization reaction with octynyl bromide 6a. An excess of this ligand was im-
portant to prevent a drop of the yield (entry 10). Other ligands were much less efficient than DPEPHos. 
Low yields were obtained with XantPhos and dppf (entries 11 and 12). While the former has similar 
electronic properties as DPEPHos, the latter displays a similar bite angle, but lacks the oxygen atom, 
  
which is a potential further weak coordination site. The bite angle of the chelating ligand is known to be 
a crucial parameter to favor reductive elimination over -hydride elimination.12 In fact, no product was 
obtained with ligands having a smaller bite angle, such as SegPhos or BINAP (entries 13 and 14). The 
efficiency of different alkynyl halides was investigated next. Both octynyl chloride (6b) and iodide (6c) 
exhibited low reactivity and gave the desired product in low yields only (entries 15 and 16). 
The choice of the base also had a strong influence on the outcome of the reaction. The use of NaOtBu 
was essential for success. Both KOtBu and LiOtBu gave the cyclized product only in traces. A modest 
yield (24%) was obtained with NaHMDS, which further supported the importance of sodium as coun-
tercation. Moreover, a base strong enough to significantly deprotonate the alcohol was required, and no 
reactivity was observed with weaker bases such as sodium carbonate or sodium acetate. While no signif-
icant effect was observed in the presence of different additives,13 the reaction temperature was found to 
be important: running the reaction at lower temperature (50 °C) led to a significantly slower transfor-
mation, with low conversion of octynyl bromide (6a). By contrast, the reaction reached 45% yield after 
just one hour at higher temperature (110 °C), but without further improvement after a longer reaction 
time. 
We concluded our studies on the optimization of the reaction with solvents and concentration effects 
(Table 2). The use of non-aromatic solvents resulted in very low yield (entries 1-5). Moderate yields 
were obtained with solvents similar to toluene, such as trifluorotoluene (entry 6) or xylene (entry 7). 
Finally, the reaction concentration had a strong effect on the reaction outcome. The yield dropped to 
35% or less when the reaction was performed at higher concentration (entry 8) than the usual reaction 
(entry 9). On the contrary, a significant improvement up to 65% was observed under more diluted condi-
tions (0.075 M) (entry 10). Further dilution did not lead to higher yields (entry 11). Under the optimized 
conditions, tetrahydrofuran 7aa could finally be isolated in 69% yield on preparative scale (entry 12).14  
Table 2: Influence of solvents and concentration. 
  
 
Entry Solvent Concentration Yielda 
1 THF 0.19 M 8% 
2 Dioxane 0.19 M nr 
3 CH3CN 0.19 M nr 
4 DMSO 0.19 M nr 
5 DCE 0.19 M nr 
6 CF3Ph 0.19 M 32% 
7 Xylene 0.19 M 42% 
8 Toluene 0.50 M 35% 
9 Toluene 0.19 M 51% 
10 Toluene 0.075 M 65% 
11 Toluene 0.019 M 62% 
12 Toluene 0.075 M 69%b 
aReaction conditions: 0.15 mmol 5a, 0.006 mmol catalyst (4 mol %), 0.012 mmol DPEPHos (8 mol 
%), 0.225 mmol 6a (1.5 equiv), 0.225 mmol NaOtBu (1.5 equiv), solvent, 3 h, 80 °C, yield was deter-
mined by GC-MS; b0.40 mmol 5a, 0.52 mmol 1-bromooctyne (6a) (1.3 equiv), 0.52 mmol NaOtBu (1.3 
equiv), 0.020 mmol catalyst (5 mol %), 0.030 mmol DPEPHos (7.5 mol %), solvent, 3 h, 80 °C, isolated 
yield after column chromatography. 
With optimized conditions in hand, we then examined the scope of the reaction. We started with varia-
tion of the bromo alkyne 6 (Scheme 2). The required aliphatic bromo acetylenes were readily prepared 
  
by bromination of terminal alkynes with a slight excess of NBS, in the presence of catalytic AgNO3.
15 In 
addition to octynyl bromide 6a, the reaction worked well with pentynyl bromides bearing different func-
tional groups in the terminal position, giving products bearing a silyl-protected alcohol (7ad, 67% yield) 
a phenyl group (7ae, 64% yield), a chloride group (7af, 56%) or a protected alkyne (7ag, 59%). The 
tolerance to a halogen atom is particularly interesting, as a Williamson etherification could have been 
expected in this case. For the first time, bromo acetylenes 6h-k derived from propargylic alcohols could 
be used in the oxyalkynylation reaction to produce products 7ah-i. This result was of particular interest 
when considering the prevalence of hydroxy substituents in bioactive natural products and also consti-
tuted a major breakthrough in the field, as propargylic or allylic alcohols had never been obtained in the 
oxyfunctionalization of alkenes before. Both benzyl and triisopropyl silyl protected groups could be 
used in the reaction to give tertiary (products 7ah and 7ai) and secondary (products 7aj and 7ak) pro-
pargylic alcohols in 63-85% yield. We then decided to examine secondary alcohols 5b and 5c as sub-
strates.16 The reaction is especially interesting in this case because the resulting 2,5-disubstituted tetra-
hydrofurans are often encountered in biologically active natural compounds (Figure 1). 2-
Phenylpentenol (5b) smoothly reacted with tertiary alkynyl bromide 6h to deliver trans-substituted tet-
rahydrofuran 7bh as the only diastereoisomer in 72% yield. Alcohol 5c, bearing a propargyl group on 
the carbinol position, was less reactive and complete conversion could not be achieved. Nonetheless, the 
oxyalkynylation with octynylbromide 6a resulted in the formation of the C2-symmetric product 7ca, in 
55% isolated yield and a 87:13 trans selectivity. 
Scheme 2: Scope of the oxyalkynylation of -hydroxyalkenes with aliphatic alkynyl bromides.a 
  
 
aReaction conditions: 0.40 mmol alcohol 5, 0.52 mmol alkynyl bromide 6 (1.3 equiv), 0.52 mmol 
NaOtBu (1.3 equiv), 0.020 mmol Pd(dba)2 (5 mol %), 0.030 mmol DPEPHos (7.5 mol %), 4.6 mL tolu-
ene, 80 °C, under N2 for 3 hours, isolated yield after column chromatography; 
b0.040 mmol Pd(dba)2 
(10 mol %), 0.060 mmol DPEPHos (15 mol %), 15 hours. 
The reaction of aliphatic alkynyl bromides with N-protected -amino alkenes was then investigated 
(Scheme 3).17 Amines at primary position gave the corresponding 2-propargyl pyrrolidines in 60-77% 
yields. In addition to octynyl bromide 6a (product 10aa), the reaction worked well with both bromo-
acetylenes bearing a protected alcohol or a phenyl group on the terminal position (products 10ad and 
10ae) and bromo derivatives of tertiary and secondary propargylic alcohols (products 10ah and 10aj). 
Amines on a secondary position gave full conversion and high diastereoselectivity in favor of the cis-
2,5-disubstituted pyrrolidines. The transformation was compatible with both aromatic (product 10ba) 
and aliphatic substituents (product 10ca) on the secondary position. The presence of a double bond in 
the lateral chain was well tolerated and compound 10da was isolated in 60% yield. Polycyclic nitrogen 
heterocycles constitute the core of a multitude of bioactive natural alkaloids. The potential of the meth-
od to access polycyclic systems were consequently examined in more detail. cis-2-Allyl cyclopentyl, 
cyclohexyl and cycloheptenyl amines 9e-g were good substrates for aminoalkynylation and give access 
  
to [5,5], [5,6] and [5.7] bicyclic heterocycles (products 10ea, 10fa, 10fl and 10ga). Aminoalkynylation 
with brominated alkynyl bromide 6l also worked well to produce amine 10fl, without alkylation of the 
carbamate. The aminoalkynylation was also highly effective in the case of N-Boc protected 2-allyl ani-
line (9h), showcasing the possibility of applying our method for the preparation of propargylic indoline 
heterocycles such as 10ha. Finally, the reaction was not limited to N-Boc-protected amines: under the 
same conditions, N-aryl substituted pyrrolidines 10ia and 10ja could be obtained in 79% and 59% yield 
respectively. 
Scheme 3: Scope of the oxyalkynylation reaction with N-Boc -aminoxyalkenes.a 
 
  
aReaction conditions: 0.40 mmol amine 9, 0.52 mmol alkynyl bromide 6 (1.3 equiv), 0.52 mmol NaOt-
Bu (1.3 equiv), 0.020 mmol Pd(dba)2 (5 mol %), 0.030 mmol DPEPHos (7.5 mol %), 4.6 mL toluene, 
80 °C, under N2 for 3 hours. 
Having effectively developed an extension of our method to aliphatic acetylenes, we turned to the re-
duction of the triple bond to obtain the alkyl chain contained in most natural products. In particular, a 
one-pot transformation without isolation and purification of the alkyne would provide very efficient 
access to this class of compounds, especially when considering that the oxy- or aminoalkylation of ole-
fins is still an unknown process. A simple switch of solvent to methanol, addition of Pd/C (5 mol %) and 
hydrogenation under a H2 atmosphere resulted in the smooth and complete in situ reduction to com-
pounds 11aa and 12aa within 12 hours (Scheme 4).18 In addition, the reaction worked by simply adding 
methanol and Pd/C to the reaction mixture, but it was much slower (more than 48 hours). Therefore, the 
removal of toluene prior to the addition of methanol, although not strictly required, was more conven-
ient. 
Scheme 4: Oxy- and aminoalkynylation followed by in situ hydrogenation with Pd/C. 
 
The developed methodology is of high interest because it allows the convergent combination of alco-
hols or amines and alkynyl bromides of similar complexity, without using a large excess of one of the 
two partners. In order to gain deeper insight into the reaction mechanism for future improvements, we 
decided to study the especially challenging coupling of secondary alcohol 5b with propargylic ether 6h 
(Scheme 5). On a 1.85 mmol scale, tetrahydrofuran 7bh could be isolated in 55% yield. Three further 
products originating from alcohol 5b could also be isolated: recovered 5b itself (13% yield), ketone 13 
  
(4% yield) and hydroxy ketone 14 (12% yield). In addition, two products derived from alkynyl bromide 
6h were obtained: reduced alkyne 15 (5% yield) and dimer 16 (36% yield). 
Scheme 5: Large-scale reaction between alcohol 5b and alkynyl bromide 6h and identification of side 
products. 
 
The high number of isolated side products further emphasizes the challenging nature of the oxy-
alkynylation process. On the other hand, it also constitutes a fascinating footprint for the potential in-
termediates of the catalytic cycle (Scheme 6). A probable first step would be oxidative addition of a 
Pd(0) complex I on alkynyl bromide 6h to give alkynyl-Pd intermediate II. This kind of organometallic 
intermediate can potentially undergo ligand exchange to form a bis-alkynyl complex, and subsequent 
reductive elimination would give the observed diyne 16.19 In fact, preventing the homocoupling of the 
alkynyl bromide is one of the major challenges of the oxyalkynylation process. Ligand exchange on Pd 
followed by intramolecular oxypalladation on III to give intermediate IV would be in agreement with 
the excellent trans diastereoselectivity observed, if the two substituents are in pseudo-equatorial posi-
tion in the transition state V. It allows also rationalizing the cis selectivity observed for pyrrolidines, as 
in this case a strong A1,3 interaction with the Boc group would make a pseudo axial position of the adja-
cent substituent more favorable.20 Furthermore, a base strong enough to form the alkoxide to allow lig-
and exchange would be required for this step, as it has been observed during the optimization of the 
reaction. However, if oxypalladation is too slow, -hydride elimination can occur on intermediate III, 
  
leading to the formation of the observed ketone 13 and alkyne 15. Finally, the last step of the catalytic 
cycle is reductive elimination to give oxyalkynylation product 7bh and regenerate the active Pd(0) cata-
lyst I. Again, -hydride elimination is possible on intermediate IV, which would lead to the formation 
of enol ether 17. Although 17 was not isolated from the reaction mixture, hydroxy ketone 14 could rea-
sonably have been formed during aqueous work-up or on silica gel during column chromatography.21 
The formation of 14 is also in agreement with insertion of the olefin into the Pd-O bond from III to 
form intermediate IV. An alternative mechanism involving first insertion into the Pd-alkynyl bond does 
not allow rationalizing the formation of 14. 
Scheme 6: Working model for the reaction mechanism of the oxyalkynylation reaction. 
 
When considering the complexity of the reaction, the required reaction temperature, the short reaction 
time and the high sensitivity to air, obtaining a precise kinetic profile for the reaction constitutes a for-
midable challenge. Nevertheless, interesting preliminary results were already obtained by studying the 
effect of reagents stoichiometry on the rate of formation of oxyalkynylation product 7bh (Figure 2). 
  
Although the many side reactions does not allow a better understanding of the reaction mechanism,22  
important practical conclusions could already be drawn from these experiments: 1) Increasing the ex-
cess of alkynyl bromide only accelerate slightly the reaction and do not lead to a significant increase in 
yield. Furthermore, the alkynyl bromide was not completely consumed in the case the reaction had 
stopped before completion. 2) In the presence of a large excess of base, product formation became much 
slower. As no extensive decomposition of starting material 5b and 6h was observed, this outcome is 
probably due to catalyst deactivation. 3) The reaction is accelerated when the catalyst loading is in-
creased and more importantly higher yields of product can be obtained, as for example in the case of the 
oxyalkynylation of propargylic alcohol 5c (Scheme 2, yield with 5 mol% catalyst: 21% yield, with 10 
mol% catalyst 55%). Taken together, these results indicate that catalyst deactivation is a major issue in 
the developed process and increasing catalyst stability will be important in the future. 
 
Figure 2. Influence of reagent stoichiometry on the formation of tetrahydrofuran 7bh. 
Conclusion 
  
In conclusion, we have described the first examples of intramolecular oxy- and aminoalkynylation of 
alkenes using aliphatic bromoacetylenes. The successful use of functionalized acetylenes in particular 
was unprecedented for the functionalization of olefins and led to a highly convergent synthesis of im-
portant tetrahydrofuran and pyrrolidine building blocks for organic synthesis. The obtained products can 
be easily hydrogenated in a one-pot transformation to give alkyl-substituted furans and pyrrolidines. A 
careful study of the side products formed during the reaction finally led to a first speculative model for 
the mechanism of the oxyalkynylation process. 
Experimental Section 
1-Phenylpent-4-en-1-ol (5b) 
 
 Following a reported procedure,16a a solution of 4-bromobutene (18) (2.30 mL, 22.8 mmol, 1.15 
equiv) in Et2O (9 mL) was added dropwise to a suspension of Mg turnings (972 mg, 40.0 mmol, 2.05 
equiv) in Et2O (18 mL) at rt. The mixture was then stirred at rt for 1 h and further refluxed for 1 h. A 
solution of benzaldehyde (2.00 mL, 20.0 mmol, 1.0 equiv) in (9 mL) was then added dropwise and the 
mixture was refluxed for 2 h. It was then poured onto ice (ca. 10 g) and treated by dropwise addition of 
HCl (aqueous solution 2.0 M). The two layers were separated and the aqueous one was extracted with 
Et2O (2 x 20 mL). The combined organic layers were washed with aqueous NaHCO3 (saturated solu-
tion, 20 mL) and brine, dried over MgSO4, filtered and the solvent was removed in vacuo. Purification 
by column chromatography (SiO2, pentane/EtOAc 95/5) afforded benzyl alcohol 5b as a colorless oil 
(1.96 g, 12.1 mmol, 60% yield). Rf 0.30 (Hexane/EtOAc 20/3); 
1H NMR (400 MHz, CDCl3) δ 7.38-7.33 
(m, 3 H), 7.29 (m, 2 H), 5.85 (ddt, 1 H, J = 16.9, 10.2, 6.6 Hz), 5.05 (ddd, 1 H, J = 17.1, 3.4, 1.6 Hz), 
4.99 (ddd, J = 10.1, 3.1, 1.2 Hz), 4.70 (ddd, 1 H, J = 7.9, 5.5, 3.4 Hz), 2.15 (m, 2 H), 1.97-1.75 (m, 3 H); 
13C NMR (101 MHz, CDCl3) δ 144.6, 138.1, 128.5, 127.6, 125.9, 114.9, 74.0, 38.0, 30.0; IR 3359 (br, 
  
w), 2932 (w), 1721 (w), 1721 (w), 1642 (w), 1603 (w), 1591 (w), 1493 (w), 1453 (w), 1416 (w), 1416 
(w), 1400 (w), 1305 (w), 1270 (w), 1239 (w), 1239 (w), 1200 (w), 1200 (w), 1175 (w), 1104 (w), 1061 
(m), 1023 (m), 1013 (m), 913 (m), 760 (m), 701 (s), 675 (m), 668 (m), 667 (m), 650 (m), 638 (m), 629 
(w), 616 (w), 606 (w). The values for the characterization of 5b correspond to the ones reported in liter-
ature.16a  
Tetradec-1-en-7-yn-5-ol (5c) 
 
 Following a reported procedure,16b 1-octyne (19) (1.94 mL, 13.0 mmol, 1.3 equiv.) was dis-
solved in THF (20 mL) and nBuLi (2.5 M in hexane, 4.8 mL, 12 mmol, 1.2 equiv.) was added at -78 °C. 
The resulting mixture was stirred for 15 min at this temperature and then warmed to 0 °C and stirred for 
1 h. A solution of epoxide 20 (1.13 mL, 10.0 mmol, 1.0 equiv.) in THF (5 mL) was added with stirring 
at -78 °C, followed by BF3•Et2O (freshly ditilled on CaH2, 1.52 mL, 12.0 mmol, 1.2 equiv.). After 7 h, 
the reaction was quenched with aqueous NH4Cl (saturated solution, 30 mL). Upon warming to rt, the 
aqueous layer was extracted with Et2O (3 x 20 mL). The combined organic layers were washed with 
brine, dried over MgSO4 and the solvent was removed in vacuo. Purification by column chromatog-
raphy (SiO2, Pentane/Et2O 10/1) afforded secondary alcohol 5c as a colorless oil (1.07 g, 5.13 mmol, 
51% yield). Rf 0.56 (Hexane/EtOAc 5/1); 
1H NMR (400 MHz, CDCl3) δ 5.83 (ddt, 1 H, J = 16.9, 10.2, 
6.6 Hz), 5.05 (dq, 1 H, J = 17.1, 1.5 Hz), 4.97 (ddd, 1 H, J = 10.0, 2.5, 1.5 Hz), 3.71 (dddd, 1 H, J = 
11.6, 6.5, 5.1, 5.1 Hz, 1 H), 2.41 (dddd, 1 H, J = 16.4, 4.7, 2.3, 2.3 Hz), 2.29 (dddd, J = 16.1, 6.5, 2.0, 
2.0 Hz), 2.25-2.09 (m, 2 H), 2.17 (tt, 2 H, J = 7.0, 2.3 Hz), 1.95 (d, 1 H, J = 5.0 Hz), 1.62 (dt, J = 8.0, 
6.5 Hz), 1.49 (quint, 2 H, J = 6.9 Hz), 1.42-1.33 (m, 2 H), 1.33-1.23 (m, 4 H), 0.89 (t, 3 H, J = 6.8 Hz); 
13C NMR (101 MHz, CDCl3) δ 138.2, 114.8, 75.8, 69.6, 65.8, 35.3, 31.3, 29.9, 28.9, 28.5, 27.8, 22.5, 
  
18.7, 14.0; IR 3374 (w), 3080 (w), 2956 (m), 2931 (s), 2872 (w), 2858 (m), 1642 (w), 1467 (w), 1466 
(w), 1455 (w), 1436 (w), 1418 (w), 1331 (w), 1120 (w), 1119 (w), 1081 (w), 1080 (w), 1062 (w), 1061 
(w), 1026 (w), 994 (w), 912 (s); HRMS (ESI) calcd for C14H25O
+ [M+H]+ 209.1900; found 209.1903. 
Tert-butyl pent-4-enylcarbamate (9a)  
 
 Following a reported procedure,17f a suspension of LiAlH4 (1.72 g, 45.1 mmol, 1.7 equiv) in 
Et2O (45 mL) was slowly added to a solution of 4-pentenamide (21) (2.65 g, 26.5 mmol, 1.0 equiv) in 
Et2O (26 mL) at 0 °C. The resulting mixture was stirred at rt overnight and then diluted with Et2O (300 
mL). Aqueous NaOH (10.0 M) was cautiously added dropwise, until complete precipitation of the in-
soluble materials. After filtration, the solids were washed with Et2O (3 x 100 mL). The combined organ-
ic layers were dried over MgSO4, filtered and the solvent was removed in vacuo. Purification by column 
chromatography (SiO2, CH2Cl2/ULTRA 95/5 to 50/50) afforded 4-pentenamine (22 as a colorless oil 
(0.907 g, 10.5 mmol, 40% yield). An impoved yield was obtained when HCl in MeOH (1.25 M, ca. 9 
mL) was added under stirring to the etheral solution of the amine. In this case, removal of the solvent in 
vacuo afforded the 4-pentenamine hydrochloride (23) as a colorless solid (930 mg, 7.64 mmol, 81% 
yield). 
 Following a slightly modified version of a reported procedure,17d Et3N (3.25 mL, 23.4 mmol, 2.2 
equiv) was added to a solution of Boc2O (2.55 g, 11.7 mmol, 1.1 equiv) in CH2Cl2 (16 mL) and the mix-
ture was stirred at 0 °C for 5 min. 4-Pentenamine (23) (0.907 g, 10.6 mmol, 1.0 equiv) in CH2Cl2 (16 
mL) was then added at 0 °C and the resulting mixture was stirred at rt overnight. The solution was then 
washed with aqueous citric acid (0.1 M, 20 mL). The aqueous layer was extracted with CH2Cl2 (3 x 20 
mL); the combined organic layers were washed with aqueous NaHCO3 (saturated solution, 20 mL) and 
brine, dried over MgSO4, filtered and the solvent was removed in vacuo. Purification by column chro-
  
matography (SiO2, Pentane/EtOAc 95/5 to 80/20) afforded protected pentenamine 9a as a pale yellow 
oil (1.73 g, 9.33 mmol, 88% yield). Rf 0.32 (Hexane/EtOAc 20/2); 
1H NMR (400 MHz, CDCl3) δ 5.80 
(ddt, 1 H, J = 16.9, 10.2, 6.7 Hz), 5.03 (dq, 1 H, J = 17.1, 1.7 Hz), 4.97 (ddd, 1 H, J = 11.3, 2.0, 1.1 Hz), 
4.52 (m, 1 H), 3.13 (q, 2 H, J = 6.6 Hz), 2.08 (m, 2 H), 1.58 (quint, 1 H, J = 7.4 Hz), 1.44 (s, 9 H); 13C 
NMR (101 MHz, CDCl3) δ 155.9, 137.7, 114.9, 78.9, 40.0, 30.9, 29.1, 28.3; IR 3349 (w), 2978 (m), 
2933 (m), 2870 (w), 1692 (s), 1643 (w), 1525 (m), 1453 (w), 1392 (w), 1367 (m), 1271 (m), 1252 (m), 
1173 (s), 1044 (w), 995 (w), 977 (w), 913 (m), 874 (w), 782 (w), 666 (w), 638 (w). The 1H NMR values 
for the characterization for 9a correspond to the ones reported in literature.17d  
Tert-butyl 1-phenylpent-4-enylcarbamate (9b) 
 
 Following a reported procedure,17e a solution of 4-bromobutene (18) (1.6 mL, 16 mmol, 1.0 
equiv) in THF (18 mL) was added dropwise to a suspension of Mg turnings (397 mg, 16.3 mmol, 1.02 
equiv) in THF (2 mL) at rt; the resulting mixture was then stirred at rt for 1 h. CuI (152 mg, 0.798 
mmol, 0.05 equiv) was added to a solution of benzoyl chloride (1.9 mL, 16 mmol, 1.0 equiv) in THF 
(17 mL) at -15 °C and the resulting mixture was stirred at the same temperature for 10 min. The Gri-
gnard reagent previously prepared was then added dropwise over 1 h at -15 °C. The mixture was stirred 
at -15 °C for additionally 2 h and then allowed to warm to rt. THF was removed by distillation under 
reduced pressure and the residue was treated with CH2Cl2 (30 mL) and aqueous HCl (1.0 M, 20 mL). 
The two layers were separated and the aqueous one was extracted with CH2Cl2 (3 x 30 mL). The com-
bined organic layers were washed with aqueous NaHCO3 (saturated solution), dried over MgSO4, fil-
tered and the solvent was removed in vacuo. Purification by column chromatography (SiO2, Pen-
tane/EtOAc 95/5) afforded ketone 24 as a pale yellow oil (2.44 g, 15.2 mmol, 95% yield).  
  
 Ketone 24 (2.30 g, 14.3 mmol, 1.0 equiv) was dissolved in MeOH (43 mL). Ammonium acetate 
(18.0 g, 233 mmol, 16.3 equiv), NaBH3CN (1.53 g, 24.4 mmol, 1.7 equiv) and activated molecular 
sieves 4Å were added and the resulting mixture was stirred at rt for 24 h. The reaction was then 
quenched by dropwise addition of aqueous HCl (37% w/v, ca. 20 mL) until pH 2. The organic solvent 
was removed under reduced pressure and the residue diluted with water (15 mL). The aqueous layer was 
washed with Et2O (2 x 35 mL) and treated by addition of solid KOH until pH 12. It was then extracted 
with Et2O (4 x 25 mL), the combined organic layers were dried over KOH, filtered and the solvent was 
removed in vacuo to afford secondary amine 25 as a colorless oil (1.44 g, 8.95 mmol 62% yield), which 
was not further purified. 
 Secondary amine 25 (0.564 g, 3.50 mmol, 1.0 equiv) was dissolved in CH2Cl2 (10.5 mL). Et3N 
(1.1 mL, 7.7 mmol, 2.2 equiv) was added and the solution was cooled to 0 °C. Boc2O (0.840 g, 3.85 
mmol, 1.1 equiv) was added in two portions and the resulting mixture was stirred at rt overnight. The 
solution was then washed with aqueous citric acid (0.1 M, 10 mL). The aqueous layer was extracted 
with CH2Cl2 (3 x 12 mL); the combined organic layers were washed with aqueous NaHCO3 (saturated 
solution, 12 mL) and brine, dried over MgSO4, filtered and the solvent was removed in vacuo. Purifica-
tion by column chromatography (SiO2, Pentane/EtOAc 98/2 to 95/5) afforded protected amine 9b as a 
colorless solid (0.815 g, 3.11 mmol, 89% yield). Rf 0.51 (Pentane/EtOAc 20/3); 
1H NMR (400 MHz, 
CDCl3) δ 7.33 (m, 2 H), 7.25 (m, 3 H), 5.81 (ddt, 1 H, J = 16.8, 10.2, 6.5 Hz), 5.01 (ddd, J = 16.1, 3.5, 
2.0 Hz), 4.99-4.96 (m, 1 H), 4.78 (m, 1 H), 4.64 (m, 1 H), 2.09 (m, 2 H), 1.78 (m, 2 H), 1.42 (s, 9 H); 
13C NMR (101 MHz, CDCl3) δ 155.2, 142.7, 137.6, 128.5, 127.2, 126.3, 115.2, 79.3, 55.1, 36.0, 30.4, 
28.4; IR 3382 (w), 3078 (w), 3064 (w), 3030 (w), 3004 (w), 2978 (w), 2933 (w), 2360 (w), 2342 (w), 
1685 (s), 1643 (w), 1519 (s), 1452 (w), 1414 (w), 1391 (w), 1365 (m), 1321 (w), 1297 (m), 1254 (m), 
1213 (w), 1175 (s), 1122 (w), 1047 (m), 1026 (w), 1018 (w), 1000 (w), 912 (m), 868 (w), 779 (w), 765 
(m), 752 (m), 703 (s), 686 (w), 670 (w), 660 (w), 648 (w), 632 (w), 613 (w); M.p.: 81.9-84.4°C. The 
values for the characterization for 9b correspond to the ones reported in literature.23 
  
tert-Butyl undec-1-en-5-ylcarbamate (9c) 
 
Following a reported procedure,17g 4-bromobutene (18) (2.0 mL, 20 mmol, 2.5 equiv.) in THF 
(10 mL) was added dropwise to a suspension of Mg turnings (486 mg, 20.0 mmol, 2.5 equiv.) in THF (2 
mL). The resulting mixture was stirred overnight and then a solution of heptaldehyde (1.1 mL, 8.0 
mmol, 1.0 equiv.) in THF (10 mL) was added dropwise at 0 °C. The reaction was stirred for 3.5 h and 
then quenched with aqueous NH4Cl (saturated solution). The aqueous layer was extracted with Et2O (3 
x 20 mL). The combined organic layers were washed with brine, dried over MgSO4, filtered and the 
solvent was removed in vacuo. Purification by column chromatography (SiO2, Pentane/EtOAc 98/2) 
afforded the secondary alcohol 27 as a pale yellow oil (1.05 g, 6.17 mmol, 77% yield). 
Following a reported procedure,17c phthalimide (1.05 g, 7.11 mmol, 1.4 equiv.) and triphenyl 
phosphine (1.87 g, 7.11 mmol, 1.40 equiv) were dissolved in THF (37 mL). Secondary alcohol 27 (865 
mg, 5.08 mmol, 1.0 equiv) was added; DEAD (40% solution in toluene, 3.1 mL, 7.11 mmol, 1.4 equiv) 
was then added dropwise at rt over 20 min. The reaction mixture was stirred at rt for 24 h. The solvent 
was evaporated and the mixture was directly purified by column chromatorgraphy (SiO2, pen-
tane/EtOAc 20/1) to afford phthalimide 28 as a pale yellow oil (1.17 g, 3.91 mmol, 77% yield). 
Phthalimide 28 (1.16 g, 3.86 mmol, 1.0 equiv.) was dissolved in EtOH (34 mL). Hydrazine hy-
drate (0.39 mL, 8.0 mmol, 2.07 equiv.) was added and the mixture was refluxed for 7 h. The mixture 
was allowed to cool to rt. Concentrated HCl (37% w/w, ca. 10 mL) was added dropwise to quench the 
reaction and the mixture was filtered through a pad of celite. The aqueous solution was extracted with 
  
Et2O (2 x 20 mL) and treated with solid NaOH until pH 12. It was then extracted with CH2Cl2 (4 x 50 
mL). The combined organic layers were washed with brine and dried over Na2SO4, filtered and the sol-
vent was removed in vacuo to afford the secondary amine 29 (315 mg, 1.86 mmol, 48% yield) as a vis-
cous colorless oil which did not require further purification. 
Secondary amine 29 (315 mg, 1.86 mmol, 1.0 equiv) was dissolved in CH2Cl2 (4.3 mL). Et3N 
(freshly distilled on CaH2, 0.65 mL, 4.6 mmol, 2.5 equiv.) was added and the solution was cooled to 
0°C. Boc2O (567 mg, 2.60 mmol, 1.4 equiv.) was added in two portions and the resulting mixture was 
stirred at rt overnight. The solution was then washed with aqueous citric acid (0.1 M, 4 mL). The aque-
ous layer was extracted with CH2Cl2 (3 x 10 mL) and the combined organic layers were washed with 
aqueous NaHCO3 (saturated solution, 10 mL) and brine, dried over MgSO4, filtered and the solvent was 
removed in vacuo. In order to remove the excess of Boc2O,
24 crude N-protected amine 9c was dissolved 
in EtOH (7.5 mL) and imidazole was added (633 mg, 9.30 mmol, 5.0 equiv.). The resulting mixture was 
stirred for 30 min at rt, then CHCl3 (18 mL) was added and the mixture was washed with an aqueous 
HCl 1% solution (2 x 37 mL, 0-5 °C). The combined organic layers were dried over MgSO4, filtered 
and the solvent was removed in vacuo and the mixture was purified by column chromatography (SiO2, 
Pentane/EtOAc 20/1) to afford the protected secondary amine 9c as a colorless oil (287 mg, 1.07 mmol, 
57% yield). Rf 0.76 (Hexane/EtOAc 5/1); 
1H NMR (400 MHz, CDCl3) δ 5.81 (ddt, 1 H, J = 16.9, 10.2, 
6.7 Hz), 5.01 (dq, 1 H, J = 17.1, 1.7 Hz), 4.95 (ddd, 1 H, J = 10.1, 2.0, 1.3 Hz), 4.24 (m, 1 H), 3.55 (m, 
1 H), 2.08 (m, 2 H), 1.43 (s, 9 H), 1.36-1.22 (m, 12 H), 0.87 (t, 3 H,  J = 6.7 Hz); 13C NMR (101 MHz, 
CDCl3) δ 155.6, 138.3, 114.6, 78.8, 50.3, 35.6, 34.8, 31.8, 30.2, 29.2, 28.4, 25.8, 22.6, 14.1; IR 3353 
(w), 2978 (w), 2957 (w), 2931 (m), 2872 (w), 2859 (w), 1692 (s), 1642 (w), 1524 (m), 1506 (m), 1455 
(w), 1391 (w), 1366 (m), 1266 (w), 1248 (w), 1247 (w), 1173 (s), 1105 (w), 1045 (w), 1021 (w), 995 
(w), 910 (m), 857 (w); HRMS (ESI) calcd for C16H32NO2
+ [M+H]+ 270.2428; found 270.2428. 
Nona-1,8-dien-5-ol (30) 
  
 
 Following a reported procedure,17g a solution of 4-bromobutene (18) (2.0 mL, 20 mmol, 2.5 
equiv) in THF (16 mL) was added dropwise to a suspension of Mg turnings (486 mg, 20 mmol, 2.5 
equiv) in THF (2 mL) at rt. After stirring the resulting mixture for 1 h at rt, it was cooled to 0 °C and a 
solution of ethyl formate (0.65 mL, 8.0 mmol, 1.0 equiv) in THF (10 mL) was added dropwise. The 
mixture was stirred at rt for 4 h and then the reaction was quenched with aqueous NH4Cl (saturated so-
lution, 30 mL). The two layers were separated and the aqueous one was extracted with Et2O (3 x 30 
mL). The combined organic layers were washed with brine, dried over MgSO4, filtered and the solvent 
was removed in vacuo. Purification by column chromatography (SiO2, Pentane/EtOAc 90/10 to 70/30) 
afforded secondary alcohol 30 as a colorless oil (1.03 g, 7.38 mmol, 92% yield). Rf 0.29 (Hex-
ane/EtOAc 20/3); 1H NMR (400 MHz, CDCl3) δ 5.83 (ddt, 2 H, J = 16.9, 10.2, 6.7 Hz), 5.04 (ddd, 2 H, 
J = 17.1, 3.4, 1.7 Hz), 4.96 (ddd, 2 H, J = 10.2, 3.2, 1.5 Hz), 3.64 (m, 1 H), 2.16 (m, 4 H), 1.68-1.45 (m, 
5 H); 13C NMR (101 MHz, CDCl3) δ 138.5, 114.7, 70.9, 36.4, 30.0; IR 3359 (w), 3078 (w), 2997 (w), 
2979 (w), 2934 (m), 2869 (w), 2850 (w), 1642 (w), 1450 (w), 1416 (w), 1338 (w), 1317 (w), 1126 (w), 
1126 (w), 1080 (w), 1061 (w), 1053 (w), 994 (m), 947 (w), 910 (s), 736 (w), 650 (w), 650 (w), 636 (w), 
624 (w), 614 (w). The values for the characterization of 30 correspond to the ones reported in litera-
ture.17g  
Tert-butyl nona-1,8-dien-5-ylcarbamate (9d) 
 
  
 Following a reported procedure,17c phthalimide (1.93 g, 13.1 mmol, 1.40 equiv) and triphenyl 
phosphine (3.44 g, 13.1 mmol, 1.40 equiv) were dissolved in THF (74 mL). Secondary alcohol 30 (1.59 
g, 10.5 mmol, 1.0 equiv) was added; DEAD (40% solution in toluene, 6.6 mL, 15 mmol, 1.4 equiv) was 
then added dropwise at rt over 20 min. The reaction mixture was stirred at rt for 23 h. The solvent was 
removed under reduced pressure and the resulting crude oil was triturated with petroleum ether/Et2O 
(2:1 mixture) until complete precipitation of the solids. The latter were filtered off and washed with the 
same mixture of solvents. The organic layers were combined and the solvents were removed in vacuo. 
Purification by column chromatography (SiO2, Pentane/EtOAc 98/2 to 95/5) afforded phthalimide 31 as 
a colorless oil (2.32 g, 8.61 mmol, 82% yield). 
 Phthalimide 31 (2.32 g, 8.61 mmol, 1.0 equiv) was dissolved in EtOH (76 mL). Hydrazine hy-
drate (0.870 mL, 17.8 mmol, 2.07 equiv) was added and the mixture was refluxed for 7 h (during this 
time a white solid precipitated). The mixture was allowed to cool down to rt and concentrated HCl (37% 
w/w, ca. 20 mL) was added dropwise to quench the reaction. The solvent was removed by distillation 
under reduced pressure and the residual aqueous solution was washed with Et2O (2 x 30 mL) and treated 
with solid NaOH until pH 12. It was then extracted with Et2O (4 x 100 mL). The combined organic lay-
ers were washed with brine and dried over Na2SO4, filtered and the solvent was removed in vacuo. Puri-
fication by column chromatography (SiO2, CH2Cl2/ULTRA 95/5 to 50/50) afforded secondary amine 32 
as a colorless oil (0.631 g, 4.53 mmol, 53% yield). 
Secondary amine 32 (0.631 g, 4.53 mmol, 1.0 equiv) was dissolved in CH2Cl2 (10.5 mL). Et3N 
(1.6 mL, 11 mmol, 2.5 equiv) was added and the solution was cooled to 0 °C. Boc2O (1.38 g, 6.34 
mmol, 1.4 equiv) was added in two portions and the resulting mixture was stirred at rt overnight. The 
solution was then washed with aqueous citric acid (0.1 M, 10 mL). The aqueous layer was extracted 
with CH2Cl2 (3 x 10 mL); the combined organic layers were washed with aqueous NaHCO3 (saturated 
solution, 10 mL) and brine, dried over MgSO4, filtered and the solvent was removed in vacuo. Purifica-
tion by column chromatography (SiO2, Pentane/EtOAc 95/5 to 90/10) afforded protected amine 9d as a 
  
colorless solid (0.749 g, 3.13 mmol, 69% yield). Rf 0.59 (Hexane/EtOAc 20/3); 
1H NMR (400 MHz, 
CDCl3) δ 5.81 (ddt, 2 H, J = 16.9, 10.2, 6.6 Hz), 5.02 (ddd, 2 H, J = 17.1, 3.2, 1.5 Hz), 4.96 (d, 2 H, J = 
10.2 Hz), 4.25 (m, 1 H), 3.59 (m, 1 H), 2.10 (m, 4 H), 1.56 (m, 4 H), 1.44 (s, 9 H); 13C NMR (101 MHz, 
CDCl3) δ 155.6, 138.2, 114.8, 78.9, 49.9, 34.8, 30.2, 28.4; IR 3439 (w), 3341 (w), 3077 (w), 3002 (w), 
2978 (m), 2933 (m), 2853 (w), 1685 (s), 1642 (w), 1525 (m), 1452 (w), 1391 (w), 1366 (m), 1302 (w), 
1269 (w), 1248 (m), 1172 (s), 1102 (w), 1046 (w), 1023 (w), 994 (w), 910 (s), 875 (w), 861 (w), 778 
(w), 748 (w), 681 (w), 664 (w), 644 (w), 631 (w), 610 (w); M.p.: found: 38.5-40.5 °C; reported: 35.8-
36.8 °C. The values for the characterization for 9d correspond to the ones reported in literature.25 
2-Allylcyclopentanol (34) 
 
 Following a reported procedure,17a allyl magnesium bromide (1.0 M in Et2O, 20 mL, 20 mmol, 
2.5 equiv) was diluted with Et2O (20 mL). Cyclopentene oxide (33) (0.70 mL, 8.0 mmol, 1.0 equiv) was 
added dropwise to the resulting solution at rt over 15 min. The mixture was refluxed for 2.5 h. It was the 
cooled to 0 °C and then the reaction was quenched by addition of aqueous NH4Cl (saturated solution, 20 
mL). The two layers were separated and the aqueous one was extracted with Et2O (3 x 30 mL). The 
combined organic layers were washed with water (3 x 20 mL) and brine, dried over MgSO4, filtered and 
the solvent was removed in vacuo. 2-Allyl cyclopentanol (34) was obtained as a colorless oil (777 mg, 
6.16 mmol, 77% yield), which did not require further purification. 1H NMR (400 MHz, CDCl3) δ 5.85 
(dddd, 1 H, J = 17.0, 10.1, 6.8, 6.8 Hz), 5.06 (dddd, J = 17.0, 2.1, 1.4, 1.4 Hz), 5.00 (ddd, 1 H, J = 10.1, 
1.0, 1.0 Hz), 3.86 (m, 1 H), 2.18 (ddd, J = 14.1, 7.0, 7.0 Hz), 2.03 (m, 1 H), 1.91 (m, 2 H), 1.80 (m, 1 
H), 1.71 (m, 1 H), 1.65-1.51 (m, 2 H), 1.49 (d, 1 H, J = 3.1 Hz), 1.22 (m, 1 H); 13C NMR (101 MHz, 
CDCl3) δ 137.5, 115.2, 78.0, 47.1, 37.8, 34.0, 29.2, 21.5. The values for the characterization for 34 cor-
respond to the ones reported in literature.26 
  
tert-Butyl (2-allylcyclopentyl)carbamate (9e)  
 
 Following a reported procedure,17c phthalimide (1.18 g, 8.00 mmol, 1.3 equiv) and triphenyl 
phosphine (2.10 g, 8.00 mmol, 1.3 equiv) were dissolved in THF (43 mL). Secondary alcohol 34 (777 
mg, 6.16 mmol, 1.0 equiv) was added; DEAD (40% solution in toluene, 3.9 mL, 8.6 mmol, 1.4 equiv) 
was then added dropwise at rt over 20 min. The reaction mixture was stirred at rt for 23 h. The solvent 
was removed under reduced pressure and the resulting crude oil was triturated with PET/Et2O (2:1 mix-
ture) until complete precipitation of the solids. The latter were filtered off and washed with the same 
mixture of solvents. The organic layers were combined and the solvents were removed in vacuo. Purifi-
cation by column chromatography (SiO2, Pentane/EtOAc 95/5) afforded the corresponding phthalimide 
as a pale yellow oil (1.21 g, 4.73 mmol, 77% yield), which was used for the next step without character-
ization. 
 The phthalimide obtained in the previous step (1.21 g, 4.73 mmol, 1.0 equiv) was dissolved in 
EtOH (46 mL). Hydrazine hydrate (0.48 mL, 9.9 mmol, 2.1 equiv) was added and the mixture was re-
fluxed for 3 h (during this time a white solid precipitated). The mixture was allowed to cool down to rt 
and concentrated HCl (37% w/w, ca. 20 mL) was added dropwise to quench the reaction. The solvent 
was removed by distillation under reduced pressure and the residual aqueous solution was washed with 
Et2O (2 x 30 mL) and treated with solid NaOH until pH 12. It was then extracted with Et2O (4 x 100 
mL). The combined organic layers were washed with brine and dried over Na2SO4, filtered and the sol-
vent was removed in vacuo. Crude amine 35 was obtained as a pale yellow oil (ca 590 mg, 4.71 mmol, 
quantitative), which was used for the next step without further purification. 
  
Crude secondary amine 35 (590 g, 4.71 mmol, 1.0 equiv) was dissolved in CH2Cl2 (18 mL). Et3N (1.9 
mL, 13 mmol, 2.7 equiv) was added and the solution was cooled to 0 °C. Boc2O (1.48 g, 6.77 mmol, 1.4 
equiv) was added in two portions and the resulting mixture was stirred at rt overnight. The solution was 
then washed with aqueous citric acid (0.1 M, 20 mL). The aqueous layer was extracted with CH2Cl2 (3 x 
20 mL); the combined organic layers were washed with aqueous NaHCO3 (saturated solution, 20 mL) 
and brine, dried over MgSO4, filtered and the solvent was removed in vacuo. Purification by column 
chromatography (SiO2, Pentane/EtOAc 97/3 to 95/5) afforded N-Boc protected amine 9e as a colorless 
solid (560 mg, 2.48 mmol, 53% yield). Rf 0.48 (Hexane/EtOAc 5/1); Melting Point: 43.0-45.2 °C; 
1H 
NMR (400 MHz, CDCl3, 65 °C) δ 5.82 (m, 1 H), 5.02 (ddd, 1 H, J = 17.1, 3.4, 1.6 Hz), 4.97 (dddd, 1 H, 
J = 10.2, 2.1, 1.1, 1.1 Hz), 4.34 (m, 1 H), 4.03 (m, 1 H), 2.23 (m, 1 H), 2.01 (m, 1 H), 1.97-1.86 (m, 2 
H), 1.80 (m, 1 H), 1.68 (m, 1 H), 1.62-1.46 (m, 2 H), 1.46 (m, 9 H), 1.36-1.23 (m, 2 H); 13C NMR (101 
MHz, CDCl3) δ 155.6, 137.8, 115.2, 79.0, 54.4, 42.6, 34.2, 32.6, 29.4, 28.5, 21.6; IR 3451 (w), 3336 (br 
w), 3332 (w), 3076 (w), 2970 (m), 2874 (w), 1696 (s), 1642 (w), 1507 (m), 1454 (w), 1388 (m), 1365 
(m), 1311 (w), 1248 (m), 1169 (s), 1089 (w), 1045 (w), 1000 (m), 911 (m), 864 (w); HRMS (ESI) calcd 
for C13H23NNaO2
+ [M+Na]+ 248.1621; found 248.1626. 
2-Allylcyclohexanol (37) 
 
 Following a reported procedure,17a allyl magnesium bromide (1.0 M in Et2O, 20 mL, 20 mmol, 
3.0 equiv) was diluted with Et2O (16 mL). Cyclohexene oxide 36 (0.67 mL, 6.6 mmol, 1.0 equiv) was 
added dropwise to the resulting solution at rt over 15 min. The mixture was refluxed for 3 h and then the 
reaction was quenched by addition of aqueous NH4Cl (saturated solution, 30 mL). The two layers were 
separated and the aqueous one was extracted with Et2O (3 x 30 mL). The combined organic layers were 
washed with water (3 x 20 mL) and brine, dried over MgSO4, filtered and the solvent was removed in 
  
vacuo. Purification by column chromatography (SiO2, CH2Cl2/MeOH 99/1 to 96/4) afforded secondary 
alcohol 37 as a colorless oil (0.838 g, 5.98 mmol, 90% yield). Rf 0.44 (Hexane/EtOAc 20/3); 
1H NMR 
(400 MHz, CDCl3) δ 5.89 (ddt, 1 H, J = 17.2, 10.1, 7.4 Hz), 5.09 (m, 1 H), 5.05 (m, 1 H), 3.30 (m, 1 H), 
2.48 (m, 1 H), 2.09-1.92 (m, 2 H), 1.79 (m, 2 H), 1.65 (m, 2 H), 1.43-1.12 (m, 4 H), 0.98 (m, 1 H); 13C 
NMR (101 MHz, CDCl3) δ 137.5, 115.9, 74.5, 44.8, 37.4, 35.5, 30.3, 25.5, 24.9; IR 3332 (w), 2927 (s), 
2856 (s), 1639 (w), 1462 (w), 1462 (w), 1449 (m), 1415 (w), 1352 (w), 1308 (w), 1234 (w), 1214 (w), 
1195 (w), 1151 (w), 1132 (w), 1081 (w), 1061 (s), 1037 (s), 997 (w), 965 (w), 965 (w), 940 (w), 908 
(m), 844 (w), 824 (w), 790 (w), 736 (m), 709 (w), 697 (w), 687 (w), 666 (w), 647 (m), 638 (m), 629 (w), 
629 (w), 620 (w), 611 (m). The values for the characterization for 37 correspond to the ones reported in 
literature.27 
tert-Butyl (2-allylcyclohexyl)carbamate (9f) 
 
 Following a reported procedure,17c phthalimide (1.38 g, 9.36 mmol, 1.3 equiv) and triphenyl 
phosphine (2.45 g, 9.36 mmol, 1.3 equiv) were dissolved in THF (50 mL). 2-Allyl cyclohexanol (37) 
(1.00 g, 7.20 mmol, 1.0 equiv) was added; DEAD (40% solution in toluene, 4.6 mL, 10 mmol, 1.4 
equiv) was then added dropwise at rt over 20 min. The reaction mixture was stirred at rt for 23 h. The 
solvent was removed under reduced pressure and the resulting crude oil was triturated with PET/Et2O 
(2:1 mixture) until complete precipitation of the solids. The latter were filtered off and washed with the 
same mixture of solvents. The organic layers were combined and the solvents were removed in vacuo. 
Purification by column chromatography (SiO2, Pentane/EtOAc 95/5 to 90/10) afforded the correspond-
ing phthalimide as a pale yellow solid (835 mg, 3.10 mmol, 44% yield), which was used for the next 
step without characterization. 
  
 The phthalimide obtained in the previous step (835 mg, 3.10 mmol, 1.0 equiv) was dissolved in 
EtOH (27 mL). Hydrazine hydrate (0.32 mL, 6.5 mmol, 2.1 equiv) was added and the mixture was re-
fluxed for 3 h (during this time a white solid precipitated). The mixture was allowed to cool down to rt 
and concentrated HCl (37% w/w, ca. 10 mL) was added dropwise to quench the reaction. The solvent 
was removed by distillation under reduced pressure and the residual aqueous solution was washed with 
Et2O (2 x 20 mL) and treated with solid NaOH until pH 12. It was then extracted with Et2O (4 x 50 mL). 
The combined organic layers were washed with brine and dried over Na2SO4, filtered and the solvent 
was removed in vacuo. Crude amine 38 was obtained as a pale yellow oil (366 mg, 2.63 mmol, 85% 
yield), which was used for the next step without further purification. 
 Crude secondary amine 38 (366 mg, 2.63 mmol, 1.0 equiv) was dissolved in CH2Cl2 (7.7 mL). 
Et3N (freshly distilled on CaH2, 0.80 mL, 5.8 mmol, 2.2 equiv) was added and the solution was cooled 
to 0 °C. Boc2O (632 mg, 2.89 mmol, 1.1 equiv) was added in two portions and the resulting mixture was 
stirred at rt overnight. The solution was then washed with aqueous citric acid (0.1 M, 15 mL). The 
aqueous layer was extracted with CH2Cl2 (3 x 15 mL); the combined organic layers were washed with 
aqueous NaHCO3 (saturated solution, 15 mL) and brine, dried over MgSO4, filtered and the solvent was 
removed in vacuo. Purification by column chromatography (SiO2, Pentane/EtOAc 97/3) afforded N-Boc 
protected amine 9f as a colorless solid (438 mg, 1.83 mmol, 69% yield). Rf 0.75 (Hexane/EtOAc 4/1); 
Melting Point: 46.9-49.2 °C ;1H NMR (400 MHz, CDCl3) δ 5.79 (dddd, 1 H, J = 17.0, 10.2, 7.3, 7.3 
Hz), 5.02 (m, 1 H), 4.98 (m, 1 H), 4.60 (br m, 1 H), 3.83 (m, 1 H), 2.09 (m, 1 H), 1.91 (m, 1 H), 1.77-
1.46 (m, 6 H), 1.45 (s, 9 H), 1.41-1.20 (m, 2 H), 1.13 (m, 1 H); 13C NMR (101 MHz, CDCl3) δ 155.4, 
137.1, 115.8, 78.9, 49.2, 39.7, 36.2, 30.8, 28.4, 27.3, 24.3, 21.7. IR 3461 (w), 3348 (br w), 3284 (br w), 
3135 (w), 3074 (w), 2976 (w), 2929 (m), 2859 (w), 2858 (w), 1814 (w), 1697 (s), 1643 (w), 1500 (m), 
1456 (m), 1388 (m), 1365 (m), 1338 (w), 1312 (w), 1247 (m), 1170 (s), 1106 (w), 1067 (m), 975 (w), 
944 (w), 911 (m), 873 (w); HRMS (FT-Orbitrap) calcd for C14H26NO2
+ [M+H]+ 240.1958; found 
240.1949. 
  
tert-Butyl (2-allylcycloheptyl)carbamate (9g): 
 
 Following a reported procedure,17a allyl magnesium bromide (1.0 M in Et2O, 17.5 mL, 17.5 
mmol, 2.5 equiv) was diluted with Et2O (16.8 mL). Cycloheptene oxide 39 (0.81 mL, 7.0 mmol, 1.0 
equiv) was added dropwise to the resulting solution at rt over 15 min. The mixture was refluxed for 2 h. 
It was the cooled to 0 °C and then the reaction was quenched by addition of aqueous NH4Cl (saturated 
solution, 18 mL). The two layers were separated and the aqueous one was extracted with Et2O (3 x 25 
mL). The combined organic layers were washed with water (3 x 25 mL) and brine, dried over MgSO4, 
filtered and the solvent was removed in vacuo. Column chromatography (SiO2, CH2Cl2/EtOAc 97/3 to 
93/7) afforded the pure 2-allyl cycloheptanol (40) as a colorless oil (978 mg, 6.34 mmol, 91% yield), 
which was used directly in the next step. 
 Following a reported procedure,17c phthalimide (1.06 g, 7.20 mmol, 1.3 equiv) and triphenyl 
phosphine (1.89 g, 7.20 mmol, 1.3 equiv) were dissolved in THF (38 mL). Secondary alcohol 40 (855 
mg, 5.54 mmol, 1.0 equiv) was added; DEAD (40% solution in toluene, 3.5 mL, 7.8 mmol, 1.4 equiv) 
was then added dropwise at rt over 20 min. The reaction mixture was stirred at rt for 23 h. The solvent 
was removed under reduced pressure and the resulting crude oil was triturated with PET/Et2O (2:1 mix-
ture) until complete precipitation of the solids. The latter were filtered off and washed with the same 
mixture of solvents. The organic layers were combined and the solvents were removed in vacuo. Purifi-
cation by column chromatography (SiO2, Pentane/EtOAc 95/5 to 93/7) afforded the corresponding 
phthalimide as a colorless solid (1.32 g, 4.66 mmol, 84% yield), which was used directly for the next 
step. 
  
 The phthalimide obtained in the previous step (1.09 g, 3.86 mmol, 1.0 equiv) was dissolved in 
EtOH (34 mL). Hydrazine hydrate (0.47 mL, 9.6 mmol, 2.5 equiv) was added and the mixture was re-
fluxed for 3 h (during this time a white solid precipitated). The mixture was allowed to cool down to rt 
and concentrated HCl (37% w/w, ca. 20 mL) was added dropwise to quench the reaction. The solvent 
was removed by distillation under reduced pressure and the residual aqueous solution was washed with 
Et2O (2 x 30 mL) and treated with solid NaOH until pH 12. It was then extracted with Et2O (4 x 100 
mL). The combined organic layers were washed with brine and dried over Na2SO4, filtered and the sol-
vent was removed in vacuo. Crude amine 41 was obtained as a pale yellow oil (468 mg, 3.05 mmol, 
79% yield), which was used for the next step without further purification. 
Crude secondary amine 41 (460 mg, 3.00 mmol, 1.0 equiv) was dissolved in CH2Cl2 (8.8 mL). 
Et3N (freshly distilled on CaH2, 0.92 mL, 6.6 mmol, 2.2 equiv) was added and the solution was cooled 
to 0 °C. Boc2O (785 mg, 3.60 mmol, 1.4 equiv) was added in two portions and the resulting mixture was 
stirred at rt overnight. In order to remove the excess of Boc2O,
24 the solvent was then removed by evap-
oration under reduced pressure and the residue was dissolved in EtOH (12 mL). Imidazole (1.02 g, 15.0 
mmol, 5.0 equiv) was added and the mixture was stirred at rt for 15 min. The mixture was then concen-
trated in vacuo and diluted with CHCl3 (30 mL). The organic solution was then washed with aqueous 
HCl (1% v/v, 8.8 mL, 0 °C), dried over MgSO4, filtered and the solvent was removed in vacuo. Purifi-
cation by column chromatography (SiO2, pentane/EtOAc 95/5) afforded N-Boc protected amine 9g as a 
colorless viscous oil (596 mg, 2.35 mmol, 78% yield). Rf 0.57 (Hexane/EtOAc 5/1); 
1H NMR (400 
MHz, CDCl3) δ 5.77 (dddd, 1 H, J = 17.1, 10.0, 7.2, 7.2 Hz), 5.00 (ddd, 1 H, J = 14.4, 3.3, 1.5 Hz), 4.97 
(ddd, 1 H, J = 5.8, 1.8, 1.8 Hz), 4.51 (d, 1 H, J = 7.9 Hz), 3.89 (m, 1 H), 2.12 (m, 1 H), 1.90 (m, 1 H), 
1.75 (m, 1 H), 1.65 (m, 2 H), 1.62-1.42 (m, 6 H), 1.42 (s, 9 H), 1.25 (m, 2 H); 13C NMR (101 MHz, 
CDCl3) δ 155.4, 137.6, 115.8, 78.8, 52.6, 42.6, 37.3, 33.1, 28.9, 28.4, 27.7, 26.3, 23.4; IR 3455 (w), 
3344 (br w), 3075 (w), 2977 (w), 2926 (m), 2859 (w), 1696 (s), 1642 (w), 1500 (m), 1456 (w), 1389 
  
(m), 1366 (m), 1341 (w), 1319 (w), 1246 (m), 1169 (s), 1106 (w), 1047 (w), 1021 (w), 998 (w), 955 (w), 
911 (m), 889 (w); HRMS (ESI) calcd for C15H28NO2
+ [M+H]+ 254.2115; found 254.2117. 
tert-Butyl 2-allylphenylcarbamate (9h): 
 
 Following a reported procedure,17h 2-iodonitrobenzene (42) (1.74 g, 7.00 mmol, 1.0 equiv) was 
dissolved in THF (10 mL) and the solution was cooled to -40 °C. Phenyl magnesium bromide (1.0 M in 
THF, 7.7 mL, 7.7 mmol, 1.1 equiv) was added dropwise and the resulting mixture was stirred at -40 °C 
for 15 min before a solution of CuCN (627 mg, 7.00 mmol, 1.0 equiv) and LiCl (593 mg, 14.0 mmol, 
2.0 equiv) in THF (4.0 mL) was also added. The mixture was stirred for further 15 min and then allyl 
bromide (0.67 mL, 7.7 mmol, 1.1 equiv) was added. The mixture was stirred at -40 °C for 2 hours and 
then allowed to warm to rt and quenched by the addition of aqueous NH4Cl (saturated solution, ca. 10 
mL). The aqueous layer was extracted with Et2O (3 x 20 mL) and the combined organic extracts were 
treated with activated charcoal. After the latter was filtered off, the organic solution was dried over over 
MgSO4, filtered and the solvent removed by evaporation under reduced pressure. Purification by col-
umn chromatography (SiO2, Pentane/CH2Cl2 100/0 to 95/5) afforded 2-allyl nitrobenzene (43) as a pale 
yellow oil (590 mg, 3.60 mmol, 52% yield). 1H NMR (400 MHz, CDCl3) δ 7.91 (dd, 1 H, J = 8.6, 1.4 
Hz), 7.55 (d, 1H, J = 7.6, 1.2, Hz), 7.41-7.32 (m, 2 H), 5.97 (dddd, 1 H, J = 16.7, 10.1, 6.5, 6.5 Hz), 5.12 
(m, 1 H), 5.08 (m, 1 H), 3.69 (d, 2 H, J = 6.5 Hz). 
 Following a reported procedure,17i Zn (dust, 3.53 g, 54.0 mmol, 15.0 equiv) and acetic acid (3.1 
mL, 54 mmol, 15 equiv) were added to a solution of 2-allyl nitrobenzene (43) (590 mg, 3.60 mmol, 1.0 
equiv) in EtOH (36 mL). The resulting suspension was stirred at rt for 1.5 hours and then filtered 
through celite. After washing the celite pad with EtOH, the organic solution was concentrated in vacuo. 
  
Aqueous NaHCO3 (saturated solution, 30 mL) was added to the residue and the aqueous layer was ex-
tracted with EtOAc (3 x 30 mL). The combined organic extracts were washed with brine, dried over 
MgSO4, filtered and the solvent was removed in vacuo. The obtained crude oil was used for the next 
step without further purification.  
 Crude 2-allyl aniline (44) (ca. 480 mg, ca. 3.60 mmol, 1.0 equiv) was dissolved in Et2O (5.8 mL) 
and Et3N (1.1 mL, 7.9 mmol, 2.2 equiv) was added to the resulting solution, cooled to 0 °C. A solution 
of Boc2O (1.65 g, 7.54 mmol, 2.1 equiv) in Et2O (5.8 mL) was then added and the mixture was stirred at 
0 °C for 10 minutes and then at rt for 20 hours. After filtering the solids off, the resulting solution was 
concentrated in vacuo. Purification of the crude oil by column chromatography (SiO2, pentane/EtOAc 
95/5) afforded the pure N-Boc protected 2-allyl aniline 9h as a colorless oil (365 mg, 1.56 mmol, 43% 
yield). Rf 0.57 (Hexane/EtOAc 5/1); 
1H NMR (400 MHz, CDCl3) δ 7.78 (d, 1 H, J = 7.9 Hz), 7.24 (m, 2 
H), 7.14 (dd, 1 H, J = 7.6, 1.3 Hz), 7.04 (td, 1 H, J = 7.4, 1.0 Hz), 6.43 (br s, 1 H), 5.96 (dddd, 1 H, J = 
17.2, 9.9, 5.8, 5.8 Hz), 5.16 (dq, 1 H, J = 9.9, 1.5 Hz), 5.06 (dq, 1 H, J = 17.2, 1.7 Hz), 3.37 (d, 2 H, J = 
6.0 Hz), 1.51 (s, 9 H); 13C NMR (101 MHz, CDCl3) δ 153.1, 136.4, 135.8, 129.9, 128.9, 127.3, 123.9, 
121.9, 116.5, 80.2, 36.4, 28.3. IR 3430 (br w), 3335 (br w), 3003 (w), 2976 (w), 2932 (w), 2877 (w), 
2876 (w), 2871 (w), 2360 (w), 2342 (w), 2332 (w), 1731 (m), 1688 (m), 1639 (w), 1613 (w), 1589 (w), 
1513 (s), 1477 (w), 1452 (m), 1429 (w), 1412 (m), 1392 (w), 1366 (m), 1300 (w), 1299 (w), 1245 (m), 
1158 (s), 1119 (m), 1037 (w), 1028 (w), 999 (w), 919 (w), 878 (w), 843 (w), 816 (w). The data for the 
characterization of compound 9h correspond to the ones reported in the literature.23 
N-(Pent-4-en-1-yl)aniline (9i) 
 
Aniline (0.36 mL, 4.0 mmol, 1.0 equiv) was dissolved in CH2Cl2 (12 mL) and the resulting solu-
tion was cooled to 0 °C. Et3N (0.83 mL, 6.0 mmol, 1.5 equiv) was added. Pentenoyl chloride (45) (0.44 
  
mL; 4.0 mmol, 1.0 equiv) was then added dropwise and the mixture was allowed to warm to rt over-
night. It was then diluted with CH2Cl2 (10 mL) and washed with aqueous HCl (1.0 M, 20 mL), aqueous 
NaOH (1.0 M, 20 mL), water and brine, dried over MgSO4, filtered and the solvent was removed in 
vacuo. The resulting off-white solid (690 mg, 3.94 mmol, 98% yield) was used in the next step without 
further purification. 
Pentenamide 46 (683 mg, 3.90 mmol, 1.0 equiv) was dissolved in THF (4.3 mL) and the solution 
was cooled to 0 °C. A suspension of LiAlH4 (430 mg, 11.3 mmol, 2.9 equiv) in Et2O (11.3 mL) was 
added dropwise. The resulting mixture was allowed to warm to rt and stirred overnight. It was then 
cooled back to 0 °C and water (0.43 mL), aqueous NaOH (10% w/w, 0.86 mL) and again water (1.3 
mL) were added under vigorous stirring in order to induce the complete precipitation of lithium salts. 
The solids were filtered off and washed with Et2O several times. The organic solution was concentrated 
in vacuo to afford N-(pent-4-en-1-yl)aniline (9i) (585 mg, 3.63 mmol, 93% yield) as a colorless oil, 
which did not require further purification. Rf 0.43 (Hexane/EtOAc 10/1); 
1H NMR (400 MHz, CDCl3) δ 
7.22 (m, 2 H), 6.74 (t, 1 H, J = 7.2 Hz), 6.64 (m, 2 H), 5.89 (dddd, 1 H, J = 16.9, 10.2, 6.7, 6.7 Hz), 5.11 
(ddd, 1 H, J = 17.1, 3.3, 1.7 Hz), 5.05 (ddd, 1 H, J = 10.5, 3.5, 1.5 Hz), 3.65 (br s, 1 H), 3.17 (dd, 2 H, J 
= 7.0, 7.0 Hz), 2.22 (m, 2 H), 1.76 (quint, 2 H, J = 7.3 Hz); 13C NMR (101 MHz, CDCl3) δ 148.3, 138.0, 
129.2, 117.1, 115.0, 112.6, 43.3, 31.3, 28.6; IR 3411 (br w), 3077 (w), 3054 (w), 3053 (w), 3021 (w), 
3001 (w), 2976 (w), 2930 (w), 2858 (w), 1641 (w), 1603 (s), 1507 (s), 1477 (w), 1433 (w), 1371 (w), 
1320 (m), 1279 (w), 1259 (m), 1180 (w), 1153 (w), 1102 (w), 993 (m), 912 (m), 869 (w), 837 (w). The 
values for the characterization of 9i correspond to the ones reported in literature.6f 
4-Methoxy-N-(pent-4-en-1-yl)aniline (9j) 
 
  
Following a reported procedure,17b pyridine (0.22 mL, 2.8 mmol, 1.1 equiv) and DMAP (16.0 
mg, 0.125 mmol, 0.050 equiv) were added to a solution of para-anisidine (308 mg, 2.50 mmol, 1.0 
equiv) in CH2Cl2 (7.0 mL). The mixture was cooled to 0 °C and pentenoyl chloride (45) (0.30 mL, 2.8 
mmol, 1.1 equiv) was added dropwise. The mixture was allowed to warm to rt. The reaction was then 
quenched by adding aqueous HCl (10% v/v, 7.0 mL) and the aqueous layer was separated and extracted 
with CH2Cl2 (3 x 10 mL). The combined organic extracts were washed with aqueous NaHCO3 (saturat-
ed solution, 10 mL), water and brine, dried over MgSO4, filtered and the solvent was removed in vacuo. 
Purification by column chromatography (SiO2, CH2Cl2/MeOH 99/1 to 95/5) afforded pentenamide 47 as 
an off-white solid (400 mg, 1.95 mmol, 78% yield). 
Pentenamide 47 (400 mg, 1.95 mmol, 1.0 equiv) was dissolved in a mixture of THF (1.4 mL) 
and Et2O (6.1 mL) and the solution was cooled to 0 °C. A suspension of LiAlH4 (185 mg, 4.87 mmol, 
2.5 equiv) in Et2O (4.9 mL) was added dropwise. The resulting mixture was allowed to warm to rt and 
stirred overnight. It was then cooled back to 0 °C and water (0.20 mL), aqueous NaOH (10% w/w, 0.40 
mL) and again water (0.6 mL) were added under vigorous stirring in order to induce the complete pre-
cipitation of lithium salts. The solids were filtered off and washed with Et2O several times. The organic 
solution was concentrated in vacuo to afford 4-methoxy-N-(pent-4-en-1-yl)aniline (9j) (356 mg, 1.86 
mmol, 95% yield) as a brown oil, which did not require further purification. Rf 0.55 (Hexane/EtOAc 
5/1); 1H NMR (400 MHz, CDCl3) δ 6.78 (d, 2 H, J = 8.6 Hz), 6.58 (d, 2 H, J = 8.6 Hz), 5.84 (ddd, 1 H, 
J = 17.0, 10.1, 6.7 Hz), 5.06 (d, 1 H, J = 17.2 Hz), 5.00 (d, 1 H, J = 10.1 Hz), 3.75 (s, 3 H), 3.35 (br s, 1 
H), 3.10 (t, 2 H, J = 7.0 Hz), 2.17 (dd, 2 H, J = 13.7, 6.7 Hz), 1.71 (quint, 2 H, J = 7.1 Hz); 13C NMR 
(101 MHz, CDCl3) δ 151.9, 142.6, 138.0, 114.9, 114.8, 114.0, 55.7, 44.3, 31.3, 28.7; IR 3411 (w), 3077 
(w), 3054 (w), 3021 (w), 3001 (w), 2976 (w), 2930 (w), 2858 (w), 1641 (w), 1603 (s), 1507 (s), 1477 
(w), 1433 (w), 1371 (w), 1320 (m), 1279 (w), 1259 (m), 1180 (w), 1153 (w), 1153 (w), 1102 (w), 1102 
(w), 1023 (w), 993 (m), 912 (m), 869 (w), 869 (w). The values for the characterization of 9j correspond 
to the ones reported in literature.6f  
  
General procedure for the bromination of terminal alkynes:15a  
The terminal alkyne (1.0 equiv) is dissolved in acetone (ca. 6.8 mL per mmol of alkyne). N-
bromosuccinimide (1.2 equiv) and AgNO3 (0.1 equiv) are added to the resulting solution in this order 
and the mixture is stirred at rt for 3-6 hours, until complete consumption of the starting material accord-
ing to TLC. It was then poured onto iced water. The aqueous layer was extracted with pentane (3 times) 
and the combined organic extracts were dried over MgSO4, filtered and the solvent removed by evapo-
ration under reduced pressure. The bromo alkyne was isolated by column chromatography in 95-99% 
purity as judged by 1H NMR. 
2-Bromo-1-triisopropylsilyl acetylene (4) 
 
Triisopropylsilylacetylene (48) (813 mg, 4.45 mmol, 1.00 equiv) was brominated according to 
the general procedure. Bromoalkyne 4 was obtained as a colorless oil (1.16 g, 4.43 mmol, 99%) without 
further purification. 1H NMR (400 MHz, CDCl3) δ 1.20-0.97 (m, 21 H); 13C NMR (101 MHz, CDCl3) δ 
83.5, 61.7, 18.5, 11.3. The values for the characterization of 4 correspond to the ones reported in litera-
ture.28 
1-Bromooct-1-yne (6a) 
 
1-Octyne (19) (3.0 mL, 20 mmol, 1.0 equiv.) was brominated according to the general procedure. After 
purification by column chromatography (SiO2, pentane), bromoalkyne 6a was obtained as a colorless oil 
(3.33 g, 17.6 mmol, 88% yield). Rf 0.91 (Hexane); 
1H NMR (400 MHz, CDCl3) δ 2.20 (t, 2 H, J = 7.0 
Hz), 1.51 (quint, 2 H, J = 6.4 Hz), 1.42-1.33 (quint, 2 H, J = 7.1 Hz), 1.33-1.22 (m, 4 H) 0.89 (t, 3 H, J 
  
= 6.7 Hz); 13C NMR (101 MHz, CDCl3) δ 80.5, 37.4, 31.3, 28.5, 28.3, 22.5, 19.7, 14.0. The values for 
the characterization of 6a correspond to the ones reported in literature.29  
1-Chlorooct-1-yne (6b) 
 
 Following a slightly modified version of a reported procedure,15g N-Chlorosuccinimide (641 mg, 
4.80 mmol, 1.20 equiv) and AgOAc (67.0 mg, 0.400 mmol, 0.10 equiv) were added in this order to a 
solution of 1-octyne (19) (0.60 mL; 4.0 mmol, 1.0 equiv) in acetone (16.0 mL) and the solution was 
heated to reflux overnight. The mixture was poured onto ice and the resulting aqueous layer was ex-
tracted with pentane (3 x 20 mL). The combined organic layers were washed with brine, dried over 
MgSO4, filtered and the solvent was removed in vacuo. Purification by column chromatography (SiO2, 
Pentane) afforded chloro alkyne 6b as a smelly colorless oil (577 mg, 3.99 mmol, quantitative). 1H 
NMR (400 MHz, CDCl3) δ 2.16 (t, 2 H, J = 7.0 Hz), 1.50 (quint, J = 6.9 Hz, 2 H), 1.43-1.24 (m, 6 H), 
0.89 (t, 3 H, J = 6.7 Hz); 13C NMR (101 MHz, CDCl3) δ 69.7, 56.9, 31.3, 28.5, 28.4, 22.5, 18.8, 14.0. 
The values for the characterization of 6b correspond to the ones reported in literature.30 
1-Iodooct-1-yne (6c) 
 
 Following a reported procedure,15b a solution of 1-octyne (19) (0.60 mL, 4.0 mmol, 1.00 equiv) 
in THF (6.5 mL) was cooled to -78 °C and nBuLi (2.5 M in hexanes, 1.7 mL, 4.2 mmol, 1.0 equiv) was 
added dropwise. The solution was stirred at -78 °C for 15 min and then at 0 °C for 5 min; it was then 
cooled back to -78 °C and a solution of iodine (1.12 g, 4.40 mmol, 1.10 equiv) in THF (6.5 mL) was 
added dropwise. The mixture was stirred at rt for 2 hours and then diluted with Et2O and quenched with 
  
brine (ca. 15 mL). The organic layer was separated, washed with aqueous Na2S2O3 (saturated solution, 
15 mL), dried over MgSO4, filtered and the solvent was removed in vacuo. Purification by column 
chromatography (SiO2, Pentane/Et2O 98/2) afforded iodo alkyne 6c as a smelly colorless oil (932 mg, 
3.95 mmol, 99%). 1H NMR (400 MHz, CDCl3) δ 2.35 (t, 2 H, J = 7.0 Hz), 1.50 (quint, J = 7.0 Hz, 2 H), 
1.41-1.31 (m, 2 H), 1.33-1.23 (m, 4 H), 0.89 (t, 3 H, J = 6.8 Hz); 13C NMR (101 MHz, CDCl3) δ 94.8, 
65.8, 31.3, 28.4, 22.5, 20.8, 14.0, -7.6. The values for the characterization of 6c correspond to the ones 
reported in literature.29 
((5-Bromopent-4-yn-1-yl)oxy)(tert-butyl)diphenylsilane (6d) 
 
 4-Pentyn-1-ol (49) (0.46 mL, 5.0 mmol) was dissolved in CH2Cl2 (10 mL) and the solution was 
cooled to 0 °C. After the addition of imidazole (442 mg, 6.50 mmol, 1.3 equiv), tert-butyl diphenyl silyl 
chloride (1.4 mL. 5.4 mmol, 1.1 equiv) was also added, dropwise. The mixture was stirred and allowed 
to warm to rt overnight. The reaction was then quenched by the addition of water (ca. 10 mL). The 
aqueous layer was separated and extracted with CH2Cl2 (3 x 10 mL). The combined organic extracts 
were dried over MgSO4, filtered and the solvent was removed in vacuo. Purification by column chroma-
tography (SiO2, Pentane/EtOAc 98/2) afforded the O-silylated pentynol 50 as a colorless oil (1.33 g, 
4.12 mmol, 82% yield). 1H NMR (400 MHz, CDCl3) δ 7.67 (m, 4 H), 7.46-7.34 (m, 6 H), 3.75 (t, 2 H, J 
= 6.0 Hz), 2.35 (td, 2 H, J = 7.2, 2.6 Hz), 1.92 (t, 1 H, J = 2.6 Hz), 1.78 (ddd, 2 H, J = 13.1, 7.1, 6.0 Hz), 
1.05 (s, 9 H). 
 O-Silylated alcohol 50 (1.33 g. 4.12 mmol) was brominated according to the general procedure. 
After purification by column chromatography (SiO2, Pentane/EtOAc 98/2), bromoalkyne 6d was ob-
tained as a pale yellow oil (1.42 g, 3.54 mmol, 86% yield). 1H NMR (400 MHz, CDCl3) δ 7.68 (m, 4 H), 
  
7.47-7.34 (m, 6 H), 3.74 (t, 2 H, J = 5.9 Hz), 2.38 (t, 2 H, J = 7.1 Hz), 1.76 (ddd, 2 H, J = 12.9, 6.7, 5.8 
Hz), 1.06 (s, 9 H); 13C NMR (101 MHz, CDCl3) δ 135.5, 133.7, 129.6, 127.6, 79.9, 62.1, 37.8, 31.1, 
26.8, 19.2, 16.2; IR 3070 (w), 3050 (w), 2954 (w), 2932 (w), 2931 (w), 2893 (w), 2857 (w), 1590 (w), 
1470 (w), 1428 (w), 1389 (w), 1361 (w), 1189 (w), 1107 (s), 1063 (m), 1003 (w), 961 (w), 909 (w), 823 
(w); HRMS (ESI) calcd for C21
79BrH26OSi
+ [M+H]+ 401.0931; found 401.0943. 
(5-Bromopent-4-yn-1-yl)benzene (6e) 
 
Pent-4-yn-1-ylbenzene (51) (0.76 mL, 5.0 mmol, 1.0 equiv.) was brominated according to the general 
procedure. After purification by column chromatography (SiO2, pentane), bromo alkyne 6e was ob-
tained as a pale yellow oil (1.05 g, 4.71 mmol, 94% yield). Rf 0.38 (Hexane); 
1H NMR (400 MHz, 
CDCl3) δ 7.33-7.28 (m, 2 H), 7.24-7.19 (m, 3 H), 2.73 (t, 2 H, J = 7.5 Hz), 2.24 (t, 2 H, J = 7.0 Hz), 
1.86 (m, 2 H,); 13C NMR (101 MHz, CDCl3) δ 141.3, 128.5, 128.3, 125.9, 79.9, 38.1, 34.7, 29.8, 19.1. 
The values for the characterization of 6e correspond to the ones reported in literature.29  
1-Bromo-5-chloropent-1-yne (6f) 
 
 5-Chloropent-1-yne (52) (0.53 mL, 5.0 mmol, 1.0 equiv.) was brominated according to the gen-
eral procedure. After purification by column chromatography (SiO2, Pentane), bromoalkyne 6f was ob-
tained as a colorless oil (805 mg, 4.44 mmol, 89% yield). 
Rf 0.38 (Hexane); 
1H NMR (400 MHz, CDCl3) δ 3.64 (t, 2 H, J = 6.3 Hz), 2.41 (t, 2 H, J = 6.8 Hz), 1.97 
(quint, 2 H, J = 6.5 Hz); 13C NMR (101 MHz, CDCl3) δ 78.4, 43.4, 39.0, 31.0, 17.1; IR 3000 (w), 2961 
  
(m), 2915 (w), 2914 (w), 2873 (w), 2844 (w), 2843 (w), 2219 (w), 2218 (w), 1455 (w), 1442 (s), 1433 
(s), 1354 (w), 1329 (w), 1309 (m), 1290 (s), 1111 (w), 1041 (w), 1040 (w), 1034 (w), 1033 (w), 991 
(w), 990 (w), 972 (w), 945 (w), 911 (w), 854 (m); Anal. Calcd. for C5H6ClBr: C, 33.09%; H, 3.33%. 
Found: C, 33.13%; H, 3.06%. 
(7-bromohepta-1,6-diyn-1-yl)triisopropylsilane (6g): 
 
 Following a reported procedure,15e 1,6-heptadiyne (53) (0.62 mL, 5.4 mmol, 1.0 equiv) was dis-
solved in THF (8.0 mL) and the solution was cooled to -78 °C. A 1.0 M solution of LHMDS in THF 
(freshly prepared by treating HMDS (5.3 mmol) with nBuLi (2.5 M in hexanes, 2.1 mL, 5.3 mmol, 0.98 
equiv) was added dropwise over 15 min and the resulting mixture was stirred at -78 °C for 40 min. 
Triisopropyl silyl chloride (1.15 mL, 5.40 mmol, 1.0 equiv) was added dropwise over 1.5 hours at the 
same temperature and was then warmed to rt during 3 hours. The reaction was quenched by addition of 
water (10 mL) and the aqueous layer was extracted with Et2O (3 x 15 mL). The combined organic ex-
tracts were washed with aqueous HCl (1.0 M, 10 mL), dried over MgSO4, filtered and concentrated in 
vacuo. The crude oil was purified by column chromatography (SiO2, pentane) to furnish monosilylated 
diyne 54 as a colorless oil (640 mg, 2.78 mmol, 48% yield). 
 Monosilylated diyne 54 (640 mg, 2.78 mmol) was brominated according to the general proce-
dure, but using 1.3 equiv of NBS (594 mg, 3.34 mmol) and 0.3 equiv of AgNO3 (131 mg, 0.771 mmol). 
After purification by column chromatography (SiO2, pentane), bromo alkyne 6g was obtained as a col-
orless oil (803 g, 2.45 mmol, 95% yield). 1H NMR (400 MHz, CDCl3) δ 2.36 (t, 2 H, J = 7.0 Hz), 2.36 
(t, 2 H, J = 7.3 Hz), 1.74 (quint, 2 H, J = 7.0 Hz), 1.10-1.02 (m, 21 H); 13C NMR (101 MHz, CDCl3) δ 
107.5, 81.1, 79.3, 38.3, 27.6, 19.0, 18.7, 18.6, 11.3; IR 2942 (s), 2893 (m), 2865 (s), 2721 (w), 2172 
  
(m), 1464 (s), 1431 (m), 1384 (w), 1362 (w), 1343 (w), 1326 (w), 1311 (w), 1290 (w), 1241 (w), 1213 
(w), 1135 (w), 1070 (w), 1044 (m), 1019 (m), 995 (m), 919 (w), 883 (s), 840 (w); HRMS (ESI) calcd for 
C16H27
79BrSi [M+] 326.1065; found 326.1058. 
(((4-Bromo-2-methylbut-3-yn-2-yl)oxy)methyl)benzene (6h)  
 
 Following a reported procedure,15c NaH (60% suspension in mineral oil, 240 mg, 6.00 mmol, 1.2 
equiv) was added portionwise to a solution of 2-methyl-3-butyn-2-ol (55) (0.49 mL, 5.0 mmol, 1.0 
equiv) in THF (24 mL). The mixture was stirred at rt for 1 hour and then TBAI (92.0 mg, 0.250 mmol, 
0.050 equiv) and benzyl bromide (0.72 mL, 6.0 mmol, 1.2 equiv) were added in this order. The reaction 
mixture was stirred at rt overnight and then diluted with Et2O (18 mL). The organic solution was 
washed with water (3 x 15 mL), brine and dried over MgSO4. Upon filtration, it was concentrated by 
evaporation under reduced pressure and the resulting crude oil was purified by column chromatography 
(SiO2, Pentane/Et2O 95/5) to afford the pure O-benzylated alcohol 15 as a colorless oil (715 mg, 4.10 
mmol, 82% yield) which was directly used in the next step. 
 O-Benzylated alcohol 15 (523 mg, 3.00 mmol) was brominated according to the general proce-
dure. After purification by column chromatography (SiO2, Pentane/EtOAc 98/2), bromoalkyne 6h was 
obtained as a pale yellow oil (631 mg, 2.49 mmol, 83% yield). 1H NMR (400 MHz, CDCl3) δ 7.41-7.31 
(m, 4 H), 7.27 (m, 1 H), 4.62 (s, 2 H), 1.55 (s, 6 H); 13C NMR (101 MHz, CDCl3) δ 138.7, 128.3, 127.7, 
127.4, 82.4, 71.7, 66.7, 44.1, 28.7; IR 3065 (w), 3031 (w), 2985 (w), 2934 (w), 2864 (w), 2210 (w), 
1496 (w), 1454 (w), 1436 (w), 1382 (w), 1361 (w), 1235 (m), 1186 (m), 1157 (s), 1086 (m), 1055 (s), 
1030 (m), 1003 (w), 960 (w), 894 (w); HRMS (ESI) calcd for C12H13
79BrO [M] 252.0150; found . 
252.0144. 
  
((4-Bromo-2-methylbut-3-yn-2-yl)oxy)triisopropylsilane (6i) 
 
 Following a reported procedure,15h 2-methylbut-3-yn-2-ol (55) (0.34 mL, 3.5 mmol, 1.0 equiv.) 
and 2,6-lutidine (freshly distilled on CaH2, 0.41 mL, 3.5 mmol, 1.0 equiv.) were dissolved in CH2Cl2 (12 
mL). TIPSOTf (0.94 mL, 3.5 mmol, 1.0 equiv.) was added dropwise to the solution at 0 °C. The solu-
tion was allowed to warm to rt overnight and then quenched with a saturated aqueous NaHCO3 solution 
and the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were 
washed with H2O, dried over MgSO4, filtered and the solvent was removed in vacuo. Purification by 
column chromatography (SiO2, pentane) afforded TIPS-protected propargyl alcohol 56 as a colorless oil 
(622 mg, 2.59 mmol, 74% yield), which was used directly for the next step. 
 Propargyl alcohol 56 (603 mg, 2.51 mmol, 1.0 equiv.) was brominated according to the general 
procedure. After purification by column chromatography (SiO2, pentane), bromoalkyne 6i was obtained 
as a colorless oil (733 mg, 2.30 mmol, 91% yield). Rf 0.91 (Hexane); 
1H NMR (400 MHz, CDCl3) δ 
1.51 (s, 6 H), 1.18-1.03 (m, 21 H); 13C NMR (101 MHz, CDCl3) δ 85.4, 67.2, 42.7, 32.9, 18.3, 13.0; IR 
2982 (w), 2962 (w), 2961 (w), 2943 (m), 2892 (w), 2866 (m), 2214 (w), 1748 (w), 1741 (w), 1740 (w), 
1724 (w), 1464 (m), 1379 (w), 1361 (w), 1230 (m), 1205 (w), 1164 (s), 1050 (s), 1016 (w), 997 (w), 996 
(w), 953 (w), 937 (w), 909 (m), 882 (s), 842 (w); HRMS (APPI) calcd for C14
79BrH27OSi 318.1009 [M]; 
found 318.1011. 
 (((1-Bromonon-1-yn-3-yl)oxy)methyl)benzene (6j)  
  
 
 Following a slightly modified reported procedure,15d heptaldehyde (57) (1.22 mL, 8.76 mmol, 
1.0 equiv.) was added dropwise to a solution of ethynyl magnesium bromide (0.5 M in THF, 22.8 mL, 
11.4 mmol, 1.3 equiv.) at 0 °C. After 30 min, the cooling bath was removed to reach rt and the solution 
was stirred for further 2 h. The reaction was then quenched by addition of aqueous HCl (1.0 M, 15 mL) 
and the mixture was extracted with Et2O (3 x 20 mL). The combined organic layers were washed with 
brine, dried over MgSO4, filtered and the solvent was removed in vacuo. Purification by column chro-
matography (SiO2, pentane/EtOAc 20/1) afforded the corresponding propargyl alcohol as a yellow oil 
(943 mg, 6.73 mmol, 77% yield).  
 Following a reported procedure,15c the propargyl alcohol (701 mg, 5.00 mmol, 1.0 equiv.) was 
added dropwise to a suspension of NaH (168 mg, 7.00 mmol, 1.4 equiv.) in THF (24 mL). The solution 
was stirred for 2 h and then TBAI (92.3 mg, 0.250 mmol, 0.05 equiv.) and benzyl bromide (0.84 mL, 
7.0 mmol, 1.4 equiv.) were added sequentially. The resulting mixture was stirred overnight and then 
quenched by slow addition of H2O. The aqueous layer was extracted with Et2O (3 x 40 mL) and the 
combined organic layers were washed with brine, dried over MgSO4, filtered and the solvent was re-
moved in vacuo. Purification by column chromatography (SiO2, pentane/EtOAc 20/1) afforded the O-
benzylated propargyl alcohol 58 as a yellow oil (1.12 mg, 4.86 mmol, 97% yield). 
 Propargyl alcohol 58 (1.12 g, 4.86 mmol, 1.0 equiv.) was brominated according to the general 
procedure. After purification by chromatography column (SiO2, Pentane/EtOAc 98/2), bromoalkyne 6j 
was obtained as a pale yellow oil (1.06 g, 3.43 mmol, 71% yield). Rf 0.66 (Hexane/EtOAc 10/1); 
1H 
NMR (400 MHz, CDCl3) δ 7.37-7.27 (m, 5 H), 4.78 (d, 1 H, J = 11.7 Hz), 4.49 (d, 1 H, J = 11.7 Hz), 
4.09 (t, 1 H, J = 6.6 Hz), 1.74 (ddd, 2 H, J = 13.2, 6.6, 2.0 Hz), 1.44 (m, 2 H), 1.35-1.25 (m, 6 H), 0.88 
  
(t, 3 H, J = 6.7 Hz); 13C NMR (101 MHz, CDCl3) δ 137.8, 128.4, 128.0, 127.7, 79.5, 70.7, 69.6, 45.1, 
35.6, 31.7, 28.9, 25.2, 22.6, 14.1; IR 3031 (w), 2953 (s), 2928 (s), 2857 (s), 2207 (w), 1726 (w), 1725 
(w), 1705 (w), 1497 (w), 1456 (s), 1391 (w), 1377 (w), 1333 (m), 1206 (w), 1120 (w), 1092 (s), 1071 
(s), 1029 (m), 990 (w), 910 (w), 846 (w); HRMS (ESI) calcd for C16
79BrH22O
+ [M+H]+ 309.0849; found 
309.0857. 
((1-Bromonon-1-yn-3-yl)oxy)triisopropylsilane (6k) 
 
 Following a slightly modified reported procedure,15d heptaldehyde (57) (1.22 mL, 8.76 mmol, 
1.0 equiv.) was added dropwise to a solution of ethynyl magnesium bromide (0.5 M in THF, 22.8 mL, 
11.4 mmol, 1.3 equiv.) at 0 °C. After 30 min, the cooling bath was removed to reach rt and the solution 
was stirred for further 2 h. The reaction was then quenched by addition of aqueous HCl (1.0 M, 15 mL) 
and the mixture was extracted with Et2O (3 x 20 mL). The combined organic layers were washed with 
brine, dried over MgSO4, filtered and the solvent was removed in vacuo. Purification by column chro-
matography (SiO2, pentane/EtOAc 20/1) afforded the corresponding propargyl alcohol as a yellow oil 
(943 mg, 6.73 mmol, 77% yield).  
 TIPSCl (1.36 mL, 6.36 mmol, 1.1 equiv.) and DMAP (777 mg, 6.36 mmol, 1.1 equiv.) were 
dissolved in CH2Cl2 (10 mL) at rt and a solution of propargyl alcohol (810 mg, 5.78 mmol, 1.0 equiv.) 
in CH2Cl2 (30 mL) was slowly added to the reaction mixture. The reaction was stirred overnight and 
then quenched by sequential addition of H2O (36 mL) and aqueous HCl (2.0 M, 36 mL). The mixture 
was extracted with CH2Cl2 (3 x 20 mL) and the combined organic layers were washed with brine, dried 
over MgSO4, filtered and the solvent was removed in vacuo. Purification by column chromatography 
  
(SiO2, Pentane) afforded the O-silylated propargyl alcohol 59 as a colorless oil (1.04 g, 3.51 mmol, 61% 
yield).  
 O-Silylated propargyl alcohol 59 (890 mg, 3.00 mmol, 1.0 equiv.) was brominated according to 
the general procedure. After purification by column chromatography (SiO2, pentane), bromo alkyne 6k 
was obtained as a colorless oil (1.04 g, 2.77 mmol, 92% yield). Rf 0.63 (Hexane); 
1H NMR (400 MHz, 
CDCl3) δ 4.48 (t, 1 H, J = 6.3 Hz), 1.69 (m, 2 H), 1.44 (m, 2 H), 1.36-1.26 (m, 6 H), 1.17-1.04 (m, 21 
H), 0.89 (t, J = 6.7 Hz); 13C NMR (101 MHz, CDCl3) δ 82.1, 64.0, 43.6, 38.7, 31.8, 29.0, 24.9, 22.6, 
18.0, 18.0, 14.1, 12.3; IR 2942 (s), 2928 (s), 2894 (m), 2866 (s), 2212 (w), 1598 (w), 1597 (w), 1597 
(w), 1596 (w), 1592 (w), 1591 (w), 1464 (m), 1383 (w), 1367 (w), 1339 (w), 1260 (w), 1259 (w), 1119 
(m), 1096 (s), 1067 (s), 1014 (m), 998 (m), 971 (w), 920 (w), 883 (s); HRMS (ESI) calcd for 
C18
79BrH36OSi
+ [M+H]+ 375.1713; found 375.1724. 
1,9-Dibromonon-1-yne (6l) 
 
 Following a reported procedure,15f NaH (60% suspension in mineral oil, 1.28 g, 32.0 mmol, 4.0 
equiv) was added to ethylene diamine (freshly distilled from KOH, 14.4 mL) and the resulting mixture 
was stirred at rt for 1 hour. During this time, it became brown and, after being stirred at 60 °C during an 
additional hour, it finally converted into a turbid violet solution. It was then cooled to 40 °C and 3-
nonyn-1-ol (60) (1.27 mL, 8.00 mmol, 1.0 equiv) was added dropwise. The mixture was then heated 
back to 60 °C and stirred at this temperature for 2 hours. Passed this time, the mixture was allowed to 
cool down to rt and aqueous HCl (1.0 M, 15 mL) was added. The aqueous layer was separated and ex-
tracted with Et2O (3 x 20 mL). The combined organic extracts were dried over MgSO4, filtered and con-
centrated in vacuo. The crude oil was purified by column chromatography (SiO2, Pentane/EtOAc 95/5 
  
to 70/30) to furnish 8-nonyn-1-ol (61) as a yellow oil (856 mg, 6.10 mmol, 76% yield) which was used 
directly in the next step. 
 Alcohol 61 (280 mg, 2.00 mmol, 1.0 equiv) was dissolved in acetonitrile (6.8 mL). Triphenyl 
phosphine (787 mg, 3.00 mmol, 1.5 equiv) and tetrabromo methane (997 mg, 3.00 mmol, 1.5 equiv) 
were added in this order and the mixture was stirred at rt for 1 hour. The reaction was quenched by addi-
tion of aqueous NaOH (15% w/w) until pH 9 and the aqueous layer was extracted with Et2O (3 x 10 
mL). The combined organic extracts were dried over MgSO4, filtered and concentrated in vacuo. The 
crude oil was purified by column chromatography (SiO2, Pentane/EtOAc 95/5) to furnish the corre-
sponding alkyl bromide  as a yellow oil (404 mg, 1.99 mmol, quantitative), which was used directly in 
the following step. 
 The obtained alkyl bromide (404 mg, 1.99 mmol) was brominated according to the general pro-
cedure. After purification by column chromatography (SiO2, pentane), dibromo alkyne 6l was obtained 
as a colorless oil (422 g, 1.49 mmol, 75% yield). Rf 0.44 (Hexane); 
1H NMR (400 MHz, CDCl3) δ 3.41 
(t, 2 H, J = 6.8 Hz), 2.21 (t, 2 H, J = 6.9 Hz), 1.86 (quint, 2 H, J = 6.5 Hz), 1.52 (m, 2 H), 1.47-1.28 (m, 
6 H); 13C NMR (101 MHz, CDCl3) δ 80.3, 37.6, 33.9, 32.7, 28.5, 28.2, 28.1, 28.0, 19.6; IR 2951 (m), 
2929 (m), 2900 (w), 2856 (m), 1599 (w), 1490 (w), 1471 (w), 1464 (w), 1442 (w), 1433 (w), 1433 (w), 
1407 (w), 1389 (w), 1389 (w), 1361 (w), 1361 (w), 1352 (w), 1254 (m), 1223 (w), 1189 (w), 1105 (s), 
1071 (m), 1029 (w), 1007 (w), 1007 (w), 982 (w), 954 (w), 912 (w), 835 (s), 816 (w); Anal. Calcd. for 
C9H14Br2: C, 38.33%; H, 5.00%. Found: C, 38.69%; H, 5.08%. 
General procedure for the oxy- and amino- alkynylation reaction:  
Under inert atmosphere, Pd(dba)2 (11.5 mg, 0.0200 mmol, 0.05 equiv), DPEPHos (16.1 mg, 0.0300 
mmol, 0.075 equiv) and NaOtBu (50.0 mg, 0.520 mmol, 1.3 equiv) were introduced into a 5 mL vial, 
which was then sealed. Toluene was added (4.6 mL), followed by the bromo acetylene (0.520 mmol, 1.3 
equiv) and the starting material (0.40 mmol, 1.0 equiv). The mixture was stirred at 80 °C for 3 h and 
  
then allowed to cool to room temperature. The solvent was evaporated under reduced pressure. The 
crude mixture was then directly purified by column chromatography (SiO2, pentane/EtOAc 98/2 to 
96/4). 
General procedure for the deprotection of 2-propargyl N-Boc pyrrolidines: 
The N-Boc pyrrolidines 10 (1.0 equiv) is dissolved in CH2Cl2 (20 mL per mmol of protected pyrroli-
dine) and the resulting solution is cooled to 0 °C. Trifluoroacetic acid (10 mL per mmol of protected 
pyrrolidine) was added dropwise and the mixture was stirred at 0 °C for 40 min. The volatiles were then 
removed by distillation under reduced pressure. The residue was taken up in CH2Cl2 and the solution as 
washed with aqueous NaOH (2 M, three times). The combined organic layers were dried over Na2SO4, 
filtered and concentrated under reduced pressure. 
2-(Non-2-yn-1-yl)tetrahydrofuran (7aa): was prepared from 4-penten-1-ol (5a) (34.4 mg, 0.400 
mmol) and octynyl bromide (6a) (98.0 mg, 0.521 mmol). It was obtained as a colorless oil (56.4 mg, 
0.291 mmol, 69% yield). Rf 0.54 (Hexane/EtOAc 5/1); 
1H NMR (400 MHz, CDCl3) δ 3.99 (ddd, 1 H, J 
= 12.2, 6.7, 6.7 Hz), 3.90 (ddd, 1 H, J = 8.2, 7.0, 7.0 Hz), 3.76 (ddd, 1 H, J = 7.7, 7.7, 6.4 Hz), 2.43 (ddt, 
1 H, J = 16.4, 5.1, 2.4 Hz), 2.33 (ddt, 1 H, J = 16.4, 6.7, 2.4 Hz), 2.15 (tt, 2 H, J = 7.0, 2.4 Hz), 2.02 (m, 
1 H), 1.90 (m, 2 H), 1.69 (ddt, 1 H, J = 12.0, 8.7, 7.0 Hz), 1.48 (quint, 2 H, J = 7.0 Hz), 1.41-1.21 (m, 6 
H), 0.88 (t, 3 H, J = 6.8 Hz); 13C NMR (101 MHz, CDCl3) δ 81.6, 77.7, 76.5, 68.4, 31.3, 30.7, 29.0, 
28.5, 25.7, 25.6, 22.5, 18.8, 14.0; IR 2956 (m), 2928 (m), 2857 (m), 1690 (w), 1460 (w), 1436 (w), 1435 
(w), 1378 (w), 1369 (w), 1183 (w), 1110 (w), 1069 (s), 920 (w), 877 (w), 844 (w), 831 (w), 816 (w); 
HRMS (ESI) calcd for C16H30AgOSi
+ [M+H]+ 195.1743; found 195.1741. 
tert-Butyldiphenyl((6-(tetrahydrofuran-2-yl)hex-4-yn-1-yl)oxy)silane (7ad): was prepared from 4-
penten-1-ol (5a) (34.4 mg, 0.400 mmol) and alkynyl bromide 6d (208 mg, 0.519 mmol). It was obtained 
as a colorless oil (109 mg, 0.269 mmol, 67% yield). Rf 0.49 (Hexane/EtOAc 5/1); 
1H NMR (400 MHz, 
CDCl3) δ 7.67 (m, 4 H), 7.45-7.34 (m, 6 H), 3.95 (ddd, 1 H, J = 12.3, 6.7, 6.7 Hz), 3.88 (m, 1 H), 3.78-
3.70 (m, 1 H), 3.73 (t, 2 H, J = 6.1 Hz), 2.40 (ddd, 1 H, J = 13.7, 5.3, 2.3 Hz), 2.34-2.26 (m, 3 H), 1.98 
  
(m, 1 H), 1.94-1.80 (m, 2 H), 1.74 (quint, 2 H, J = 6.7 Hz), 1.63 (dddd, 1 H, J = 12.3, 8.8, 7.0, 7.0 Hz), 
1.05 (s, 9 H); 13C NMR (101 MHz, CDCl3) δ 135.9, 134.2, 129.8, 127.9, 81.3, 78.0, 77.1, 68.7, 62.9, 
32.2, 31.0, 27.1, 26.0, 25.9, 19.5, 15.7; IR 3070 (w), 3049 (w), 3026 (w), 3015 (w), 2997 (w), 2953 (w), 
2931 (m), 2857 (w), 1590 (w), 1488 (w), 1473 (w), 1463 (w), 1446 (w), 1429 (m), 1390 (w), 1361 (w), 
1189 (w), 1140 (w), 1108 (s), 1068 (s), 1032 (w), 1009 (w), 999 (w), 975 (w), 963 (w), 938 (w), 911 
(m), 910 (m), 823 (m); HRMS (ESI) calcd for C26H35O2Si
+ [M+H]+ 407.2401; found 407.2385. 
2-(6-Phenylhex-2-yn-1-yl)tetrahydrofuran (7ae): was prepared from 4-penten-1-ol (5a) (34.4 mg, 
0.400 mmol) and alkynyl bromide 6e (116 mg, 0.520 mmol). It was obtained as a pale yellow oil (58.0 
mg, 0.254 mmol, 64% yield). Rf 0.67 (Hexane/EtOAc 5/1); 
1H NMR (400 MHz, CDCl3) δ 7.28 (m, 2 
H), 7.21-7.16 (m, 3 H), 4.01 (ddd, 1 H, J = 13.5, 6.7, 5.5 Hz), 3.92 (ddd, 1 H, J = 8.2, 7.0, 6.4 Hz), 3.77 
(ddd, 1 H, J = 8.1, 7.5, 6.3 Hz), 2.72 (t, 2 H, J = 7.5 Hz), 2.46 (dddd, 1 H, J = 16.4, 5.4, 2.4, 2.4 Hz), 
2.37 (dddd, 1 H, J = 16.4, 6.7, 2.4, 2.4 Hz), 2.22-2.16 (m, 2 H), 2.05 (m, 1 H), 1.99-1.86 (m, 2 H), 1.81 
(quint, 2 H, J = 6.9 Hz), 1.72 (m, 1 H); 13C NMR (101 MHz, CDCl3) δ 141.8, 128.5, 128.3, 125.8, 81.0, 
77.6, 77.2, 68.4, 34.8, 30.7, 30.6, 25.7, 25.6, 18.3; IR 3025 (w), 2973 (w), 2943 (w), 2942 (w), 2929 
(w), 2909 (w), 2903 (w), 2885 (w), 2884 (w), 2863 (w), 1603 (w), 1496 (w), 1455 (w), 1434 (w), 1408 
(w), 1394 (w), 1370 (w), 1332 (w), 1313 (w), 1251 (w), 1243 (w), 1234 (w), 1233 (w), 1179 (w), 1067 
(s), 1032 (w), 1014 (w), 1013 (w), 1009 (w), 996 (w), 984 (w), 967 (w), 945 (w), 911 (w), 880 (w), 873 
(w), 844 (w), 838 (w), 832 (w); HRMS (ESI) calcd for C16H21O
+ [M+H]+ 229.1587; found 229.1586. 
2-(6-Chlorohex-2-yn-1-yl)tetrahydrofuran (7af): was prepared from 4- penten-1-ol (5a) (34.4 mg, 
0.400 mmol) and alkynyl bromide 6f (94.4 mg, 0.520 mmol). It was obtained as a pale yellow oil (41.5 
mg, 0.222 mmol, 56% yield). Rf 0.53 (Hexane/EtOAc 5/1); 
1H NMR (400 MHz, CDCl3) δ 3.98 (quint, 1 
H, J = 6.5 Hz), 3.90 (ddd, 1 H, J = 8.5, 7.0, 7.0 Hz), 3.76 (ddd, 1 H, J = 7.5, 6.5, 6.5 Hz), 3.64 (t, 2 H, J 
= 6.5 Hz), 2.45-2.30 (m, 4 H), 2.03 (m, 1 H), 1.97-1.82 (m, 2 H), 1.92 (quint, 2 H, J = 6.5 Hz), 1.65 (m, 
1 H); 13C NMR (101 MHz, CDCl3) δ 79.4, 77.8, 77.5, 68.4, 43.7, 31.6, 30.7, 25.7, 25.5, 16.2; IR 2961 
(w), 2953 (w), 2952 (w), 2951 (w), 2926 (w), 2914 (w), 2869 (w), 1457 (w), 1441 (w), 1435 (w), 1369 
  
(w), 1358 (w), 1357 (w), 1331 (w), 1330 (w), 1307 (w), 1292 (w), 1272 (w), 1110 (w), 1067 (s), 1009 
(w), 987 (w), 972 (w), 971 (w), 913 (m), 861 (w). HRMS (ESI) calcd for C10
37ClH16O
+ [M+H]+ 
187.0884; found 187.0889. 
Triisopropyl(8-(tetrahydrofuran-2-yl)octa-1,6-diyn-1-yl)silane (7ag): was prepared from 4- pen-
ten-1-ol (5a) (34.4 mg, 0.400 mmol) and alkynyl bromide 6g (170 mg, 0.520 mmol). It was obtained as 
a pale yellow oil (76.7 mg, 0.230 mmol, 59% yield). Rf 0.34 (Hexane/EtOAc 20/1); 
1H NMR (400 
MHz, CDCl3) δ 3.98 (ddd, 1 H, J = 12.2, 6.5, 6.5 Hz), 3.89 (dd, 1 H, J = 14.7, 7.0 Hz), 3.75 (dd, 1 H, J 
= 14.0, 7.4 Hz), 2.42 (m, 1 H), 2.26-2.38 (m, 5 H), 2.02 (m, 1 H), 1.90 (m, 2 H), 1.75-1.64 (m, 1 H), 
1.70 (quint, J = 7.0 Hz), 0.97-1.13 (m, 21 H); 13C NMR (101 MHz, CDCl3) δ 108.1, 80.7, 80.5, 77.6, 
77.3, 68.4, 30.7, 28.3, 25.7, 25.6, 19.0, 18.6, 17.9, 11.3; IR 2942 (s), 2865 (s), 2361 (w), 2172 (m), 2172 
(m), 1684 (w), 1683 (w), 1462 (m), 1374 (w), 1336 (w), 1320 (w), 1070 (s), 999 (w), 921 (w), 883 (m); 
HRMS (APPI) calcd for C21H36OSi [M] 332.2535; found 332.2532. 
2-(4-(Benzyloxy)-4-methylpent-2-yn-1-yl)tetrahydrofuran (7ah): was prepared from 4- penten-1-ol 
(5a) (34.4 mg, 0.400 mmol) and alkynyl bromide 6h (132 mg, 0.520 mmol). It was obtained as a pale 
yellow oil (87.5 mg, 0.338 mmol, 85% yield). Rf 0.53 (Hexane/EtOAc 5/1); 
1H NMR (400 MHz, 
CDCl3) δ 7.44-7.33 (m, 4 H), 7.29 (m, 1 H), 4.66 (s, 2 H), 4.06 (ddd, 1 H, J = 13.7, 6.9, 4.9 Hz), 3.94 
(ddd, 1 H, J = 8.2, 7.0, 7.0 Hz), 3.80 (ddd, 1 H, J = 7.4, 7.4, 6.4 Hz), 2.56 (dd, 1 H, J = 16.5, 4.8 Hz), 
2.45 (dd, 1 H, J = 16.5, 7.2 Hz), 2.08 (m, 1 H), 2.02-1.85 (m, 2 H), 1.77 (ddt, J = 12.0, 8.8, 7.0 Hz), 1.56 
(s, 6 H); 13C NMR (101 MHz, CDCl3) δ 139.2, 128.2, 127.6, 127.2, 83.7, 81.2, 77.2, 70.7, 68.5, 66.3, 
30.6, 29.1, 25.7, 25.4; IR 3031 (w), 2980 (w), 2934 (w), 2907 (w), 2866 (w), 2865 (w), 2238 (w), 1497 
(w), 1455 (w), 1454 (w), 1379 (w), 1360 (w), 1249 (w), 1187 (w), 1156 (m), 1063 (s), 1030 (w), 921 
(w), 873 (w); HRMS (ESI) calcd for C17H23O2
+ [M+H]+ 259.1693; found 259.1704. 
Triisopropyl((2-methyl-5-(tetrahydrofuran-2-yl)pent-3-yn-2-yl)oxy)silane (7ai): was prepared 
from 4- penten-1-ol (5a) (34.4 mg, 0.400 mmol) and alkynyl bromide 6i (166 mg, 0.520 mmol). It was 
obtained as a pale yellow oil (94.0 mg, 0.290 mmol, 72% yield). Rf 0.81 (Hexane/EtOAc 5/1); 
1H NMR 
  
(400 MHz, CDCl3) δ 3.97 (ddd,1 H, J = 14.4, 6.7, 4.8 Hz), 3.88 (ddd, 1 H, J = 8.2, 7.2, 6.3 Hz), 3.74 
(ddd, 1 H, J = 8.3, 7.4, 6.5 Hz), 2.47 (dd, 1 H, J = 16.4, 4.7 Hz), 2.29 (dd, 1 H, J = 16.5, 7.9 Hz), 2.02 
(m, 1 H), 1.96-1.81 (m, 2 H), 1.68 (m, 1 H), 1.18-1.00 (m, 21 H); 13C NMR (101 MHz, CDCl3) δ 87.1, 
78.9, 77.3, 68.3, 66.2, 33.4, 30.7, 25.7, 25.6, 18.3, 13.0; IR 2961 (m), 2943 (m), 2942 (m), 2890 (w), 
2865 (m), 1754 (w), 1744 (w), 1464 (m), 1435 (w), 1434 (w), 1377 (w), 1360 (w), 1245 (m), 1244 (m), 
1162 (s), 1050 (s), 1049 (s), 1017 (w), 996 (w), 969 (w), 956 (w), 935 (w), 920 (w), 904 (w), 882 (m); 
HRMS (ESI) calcd for C19H37O2Si
+ [M+H]+ 325.2557; found 325.2550.  
2-(4-(Benzyloxy)dec-2-yn-1-yl)tetrahydrofuran (7aj): was prepared from 4- penten-1-ol (5a) (34.4 
mg, 0.400 mmol) and alkynyl bromide 6j (161 mg, 0.520 mmol). It was obtained as a pale yellow oil 
(79.6 mg, 0.253 mmol, 63% yield; inseparable mixture of diastereoisomers, d.r. 1/1 – the differentiation 
between the two diastereoisomers is only visible in 13C-NMR spectrum). Rf 0.62 (Hexane/EtOAc 5/1); 
1H NMR (400 MHz, CDCl3) δ 7.41-7.31 (m, 4 H), 7.28 (m, 1 H), 4.79 (d, 1 H, J = 11.8 Hz), 4.51 (d, 1 
H, J = 11.8 Hz), 4.12-4.01 (m, 3 H), 3.92 (ddd, 1 H, J = 7.6, 6.7, 6.7 Hz), 3.78 (dd, 1 H, J = 14.1, 7.4 
Hz), 2.56 (ddd, 1 H, J = 16.5, 4.9, 1.8 Hz), 2.44 (dddd, 1 H, J = 16.5, 7.1, 0.9, 0.9 Hz), 2.06 (m, 1 H), 
2.01-1.84 (m, 2 H), 1.81-1.66 (m, 3 H), 1.55-1.38 (m, 2 H), 1.40-1.22 (m, 6 H), 0.83 (m, 3 H); 13C NMR 
(101 MHz, CDCl3) δ 138.2, 128.2, 127.9, 127.5, 82.7, 80.5, 80.5, 77.2, 70.2, 68.9, 68.4, 36.0, 31.7, 30.7, 
28.9, 25.7, 25.5, 25.3, 22.5, 14.0; IR 3062 (w), 3027 (w), 2927 (m), 2914 (m), 2908 (m), 2867 (m), 1690 
(w), 1651 (w), 1645 (w), 1634 (w), 1624 (w), 1604 (w), 1586 (w), 1557 (w), 1543 (w), 1496 (m), 1454 
(s), 1430 (m), 1406 (m), 1381 (w), 1357 (w), 1341 (w), 1249 (w), 1199 (w), 1186 (w), 1156 (m), 1080 
(m), 1059 (s), 1031 (m), 1002 (w), 960 (w), 911 (w), 875 (w), 840 (w), 834 (w), 823 (w), 812 (w); 
HRMS (ESI) calcd for C21H31O2
+ [M+H]+ 315.2319; found 315.2320. 
Triisopropyl((1-(tetrahydrofuran-2-yl)dec-2-yn-4-yl)oxy)silane (7ak): was prepared from 4- pen-
ten-1-ol (5a) (34.4 mg, 0.400 mmol) and alkynyl bromide 6k (199 mg, 0.520 mmol). It was obtained as 
a pale yellow oil (118 mg, 0.310 mmol, 78% yield; inseparable mixture of diastereoisomers, d.r. 1/1 – 
the differentiation between the two diastereoisomers is only visible in 13C-NMR spectrum). Rf 0.77 
  
(Hexane/EtOAc 5/1); 1H NMR (400 MHz, CDCl3) δ 4.44 (m, 1 H), 3.99 (ddd, 1 H, J = 13.9, 7.0, 4.7 
Hz), 3.88 (m, 1 H), 3.75 (ddd, 1 H, J = 8.2, 7.4, 6.3 Hz), 2.50 (ddd, 1 H, J = 4.6, 2.0, 2.0 Hz), 2.33 (ddd, 
J = 4.6, 2.0, 2.0 Hz), 2.04 (m, 1 H), 1.98-1.81 (m, 2 H), 1.72 (m, 1 H), 1.69-1.62 (m, 2 H), 1.49-1.38 (m, 
2 H), 1.36-1.21 (m, 6 H), 1.18-1.03 (m, 21 H), 0.89 (t, 3 H, J = 6.7 Hz); 13C NMR (101 MHz, CDCl3, 
resolved signals corresponding to different diastereoisomers are reported in italics)31 δ 83.5, 83.5, 80.7, 
68.4, 68.3, 63.2, 39.2, 31.8, 30.7, 29.1, 25.7, 25.7, 25.6, 25.6, 25.0, 22.6, 18.1, 18.0, 14.1; IR 2942 (s), 
2895 (m), 2865 (s), 1464 (m), 1383 (w), 1383 (w), 1367 (w), 1341 (w), 1256 (w), 1250 (w), 1151 (w), 
1089 (s), 1070 (s), 1014 (w), 998 (w), 920 (w), 883 (m). ); HRMS (ESI) calcd for C23H45O2Si
+ [M+H]+ 
381.3183; found 381.3196.  
2-(4-(Benzyloxy)-4-methylpent-2-yn-1-yl)-5-phenyltetrahydrofuran (7bh): was prepared from al-
cohol 5b (65.0 mg, 0.401 mmol) and alkynyl bromide 6h (132 mg, 0.520 mmol). It was obtained as a 
colorless oil (96.3 mg, 0.288 mmol, 72% yield).32 Rf 0.65 (Hexane/EtOAc 5/1); 
1H NMR (400 MHz, 
CDCl3) δ 7.40-7.28 (m, 7 H), 7.28-7.20 (m, 3 H), 5.06 (dd, 1 H, J = 7.9, 6.7 Hz), 4.65 (s, 2 H), 4.37 
(ddd, 1 H, J = 13.6, 6.9, 4.7 Hz), 2.62 (dd, 1 H, J = 16.6, 4.6 Hz), 2.53 (dd, 1 H, J = 16.5, 7.2 Hz), 2.38 
(m, 1 H), 2.21 (m, 1 H), 2.00-1.82 (m, 2 H), 1.54 (s, 6 H); 13C NMR (101 MHz, CDCl3) δ 143.2, 139.2, 
128.3, 128.3, 127.6, 127.2, 127.2, 125.5, 84.0, 82.2, 81.1, 77.9, 70.8, 66.4, 35.2, 31.5, 29.2, 25.8; IR 
3063 (w), 3030 (w), 2980 (w), 2933 (w), 2912 (w), 2911 (w), 2865 (w), 1604 (w), 1495 (w), 1453 (w), 
1380 (w), 1359 (w), 1249 (w), 1186 (w), 1156 (m), 1084 (m), 1057 (s), 1031 (m), 1002 (w), 967 (w), 
922 (w), 874 (w), 818 (w); HRMS (ESI) HRMS (ESI) calcd for C23H27O2
+ [M+H]+ 335.2006; found 
335.2006. 
2,5-Di(non-2-yn-1-yl)tetrahydrofuran (7ca): was prepared from alcohol 5c (77.7 mg, 0.400 mmol) 
and octynyl bromide (6a) (98.0 mg, 0.521 mmol) following the general procedure, but using 0.10 equiv 
Pd(dba)2 (23.0 mg, 0.0400 mmol) and 0.15 equiv DPEPHos (32.3 mg, 0.0600 mmol). It was obtained as 
a pale yellow oil (69.9 mg, 0.221 mmol, 55% yield, 95% pure; mixture of inseparable diastereoisomers, 
d.r. trans/cis 87/13).33 Rf 0.64 (Hexane/EtOAc 5/1); 
1H NMR (400 MHz, CDCl3) δ 4.14 (m, 2 H), 2.42 
  
(dddd, 2 H, J = 13.1, 7.3, 2.5, 2.5 Hz), 2.30 (dddd, 2 H, J = 16.4, 7.3, 2.4, 2.4 Hz), 2.16-2.06 (m, 4 H), 
1.76 (m, 2 H), 1.45 (quint, 4 H, J = 6.8 Hz), 1.35 (m, 2 H), 1.31-1.22 (m, 12 H), 0.87 (t, 6 H, J = 6.7 
Hz); 13C NMR (101 MHz, CDCl3, resolved signals corresponding to the minor diastereoisomer are re-
ported in italics) δ 81.8, 81.6, 78.4, 78.0, 76.5, 76.3, 31.3, 30.9, 30.2, 28.9, 28.9, 28.5, 28.5, 25.8, 25.7, 
22.5, 18.7, 14.0; IR 2956 (m), 2929 (s), 2871 (m), 2857 (m), 1581 (w), 1465 (m), 1444 (w), 1435 (w), 
1379 (w), 1367 (w), 1359 (w), 1345 (w), 1330 (w), 1314 (w), 1068 (s), 911 (m), 888 (w); HRMS (ESI) 
calcd for C22H37O
+ [M+H]+ 317.2839; found 317.2847. 
tert-Butyl 2-(non-2-yn-1-yl)pyrrolidine-1-carboxylate (10aa): was prepared from N-Boc-4-
pentenamine (9a) (74.5 mg, 0.400 mmol) and octynyl bromide (6a) (98.0 mg, 0.521 mmol). It was ob-
tained as a pale yellow oil (84.4 mg, 0.288 mmol, 72% yield); Rf 0.60 (Hexane/EtOAc 5/1). The product 
was obtained as a mixture of rotamers. In order to characterize it, it was subjected to deprotection of the 
amino group according to the general procedure. 
2-(Non-2-yn-1-yl)pyrrolidine (10aa'): was obtained as a yellow oil (62.6 mg, 0.324 mmol, quantita-
tive); 1H NMR (400 MHz, CDCl3) δ 3.16 (dt, 1 H, J = 13.0, 6.5 Hz), 3.02 (ddd, 1 H, J = 10.4, 7.5, 5.6 
Hz), 2.85 (ddd, J = 10.3, 7.6, 6.7 Hz), 2.37-2.25 (m, 2 H), 2.14 (tt, 2 H, J = 6.9, 2.4 Hz), 2.05 (m, 1 H, br 
s), 1.86 (m, 1 H), 1.81-1.68 (m, 2 H), 1.51-1.41 (m, 3 H), 1.41-1.20 (m, 6 H), 0.88 (t, 3 H, J = 6.8 Hz); 
13C NMR (101 MHz, CDCl3) δ 81.7, 77.3, 57.7, 46.6, 31.3, 30.7, 29.0, 28.5, 25.5, 25.4, 22.6, 18.7, 14.0; 
IR 3332 (br w), 2956 (s), 2928 (s), 2857 (s), 2116 (w), 1748 (w), 1748 (w), 1725 (w), 1725 (w), 1692 
(w), 1612 (w), 1554 (w), 1462 (w), 1429 (w), 1429 (w), 1403 (w), 1352 (w), 1331 (w), 1283 (w), 1245 
(w), 1152 (w), 1092 (w), 957 (w), 956 (w), 911 (w), 810 (w); HRMS (ESI) calcd for C13H24N
+ [M+H]+ 
194.19033; found 194.19044. 
tert-Butyl 2-(6-((tert-butyldiphenylsilyl)oxy)hex-2-yn-1-yl)pyrrolidine-1-carboxylate (10ad): was 
prepared from N-Boc-4-pentenamine (9a) (74.5 mg, 0.400 mmol) and alkynyl bromide 6d (208 mg, 
0.519 mmol). It was obtained as a pale yellow oil (144 mg, 0.288 mmol, 72% yield); Rf 0.50 (Hex-
  
ane/EtOAc 5/1). The product was obtained as a mixture of rotamers. In order to characterize it, it was 
subjected to deprotection of the amino group according to the general procedure. 
2-(6-((tert-Butyldiphenylsilyl)oxy)hex-2-yn-1-yl)pyrrolidine (10ad'): was obtained as a yellow oil 
(117 mg, 0.288 mmol, quantitative); 1H NMR (400 MHz, CDCl3) δ 7.73 (dd, 4 H, J = 7.4, 1.6 Hz), 7.42-
7.33 (m, 6 H), 3.71 (t, 2 H, J = 5.7 Hz), 3.09 (ddd, 1 H, J = 12.8, 6.2, 6.2 Hz), 3.05-2.86 (m, 2 H), 2.94 
(ddd, 1 H, J = 10.5, 7.5, 5.5 Hz), 2.76 (ddd, 2 H, J = 10.5, 7.0, 7.0 Hz), 2.34-2.20 (m, 3 H), 1.76-1.62 
(m, 2 H), 1.71 (quint, 2 H, J = 6.5 Hz), 1.41 (dddd, 1 H, J = 12.5, 7.5, 7.5, 7.5 Hz), 1.05 (s, 9 H); 13C 
NMR (101 MHz, CDCl3) δ 135.5, 133.8, 129.6, 127.6, 83.4, 74.0, 62.4, 58.6, 45.9, 31.6, 29.6, 26.8, 
23.3, 22.1, 19.2, 15.2; IR 3341 (w), 3069 (w), 3049 (w), 2953 (m), 2932 (m), 2889 (m), 2888 (m), 2856 
(m), 1688 (m), 1591 (w), 1468 (m), 1429 (s), 1393 (w), 1393 (w), 1359 (w), 1359 (w), 1334 (w), 1305 
(w), 1304 (w), 1259 (w), 1238 (w), 1204 (w), 1204 (w), 1191 (w), 1191 (w), 1145 (w), 1111 (s), 1063 
(m), 1004 (w), 1004 (w), 970 (w), 936 (w), 876 (m), 876 (m), 822 (m); HRMS (ESI) calcd for 
C26H36NOSi
+ [M+H]+ 406.2561; found 406.2562. 
tert-Butyl 2-(7-phenylhept-2-yn-1-yl)pyrrolidine-1-carboxylate (10ae):was prepared from N-Boc-
4-pentenamine (9a) (74.5 mg, 0.400 mmol) and alkynyl bromide 6e (116 mg, 0.520 mmol). It was ob-
tained as a pale yellow oil (101 mg, 0.308 mmol, 77% yield); Rf 0.52 (Hexane/EtOAc 5/1). The product 
was obtained as a mixture of rotamers. In order to characterize it, it was subjected to deprotection of the 
amino group according to the general procedure. 
2-(6-Phenylhex-2-yn-1-yl)pyrrolidine (10ae'): was obtained as a yellow oil (52.3 mg, 0.230 mmol, 
74% yield); 1H NMR (400 MHz, CDCl3) δ 7.31 (m, 2 H), 7.23-7.18 (m, 3 H), 3.80 (br s, 1 H), 3.28 
(ddd, 1 H, J = 13.3, 7.0, 6.4 Hz), 3.10 (ddd, 1 H, J = 10.5, 7.5, 5.8 Hz), 2.95 (ddd,1 H, J = 10.6, 7.9, 6.7 
Hz), 2.73 (t, 2 H, J = 7.5 Hz), 2.44-2.39 (m, 2 H), 2.20 (tt, 2 H, J = 7.0, 2.3 Hz), 1.96 (m, 1 H), 1.90-
1.74 (m, 4 H), 1.83 (quint, 2 H, J = 6.9 Hz), 1.56 (m, 1 H); 13C NMR (101 MHz, CDCl3) δ 141.7, 128.4, 
128.3, 125.8, 81.5, 77.4, 57.8, 46.4, 34.8, 30.6, 30.6, 25.2, 24.9, 18.2; IR 3087 (w), 3078 (w), 3063 (w), 
3062 (w), 3026 (w), 3008 (w), 2995 (w), 2939 (s), 2932 (s), 2861 (m), 2860 (m), 2112 (w), 2111 (w), 
  
2108 (w), 2107 (w), 2091 (w), 2090 (w), 2089 (w), 1950 (w), 1949 (w), 1944 (w), 1943 (w), 1687 (s), 
1635 (w), 1603 (w), 1496 (m), 1455 (s), 1430 (m), 1408 (m), 1353 (w), 1352 (w), 1334 (w), 1294 (w), 
1229 (w), 1201 (s), 1176 (s), 1175 (s), 1130 (m), 1101 (w), 1090 (w), 1089 (w), 1082 (w), 1057 (w), 
1050 (w), 1032 (w), 965 (w), 954 (w), 943 (w), 911 (m), 882 (w), 881 (w), 861 (w), 827 (m), 814 (w); 
HRMS (ESI) calcd for C16H22N
+ [M+H]+ 228.1747; found 228.1749. 
tert-Butyl 2-(4-(benzyloxy)-4-methylpent-2-yn-1-yl)pyrrolidine-1-carboxylate (10ah): was pre-
pared from N-Boc-4-pentenamine (9a) (74.5 mg, 0.400 mmol) and alkynyl bromide 6k (132 mg, 0.520 
mmol). It was obtained as a pale yellow oil (106 mg, 0.298 mmol, 74% yield, mixture of rotamers); Rf 
0.64 (Hexane/EtOAc 5/1); 1H NMR (400 MHz, CDCl3) δ 7.39-7.29 (m, 3 H), 7.25 (m, 2 H), 4.60 (s, 2 
H), 3.94 (m, 1 H), 3.82 (m, 1 H), 3.49-3.29 (m, 2 H), 2.66 (m, 1 H), 2.57 (m, 1 H), 2.45 (m, 1 H), 2.09-
1.86 (m, 3 H), 1.79 (m, 1 H), 1.51 (s, 6 H), 1.47 (s, 9 H), 1.46 (m, 9 H); 13C NMR (101 MHz, CDCl3; 
the signals of resolved rotamers are reported in italics) δ 154.3, 154.2, 139.2, 128.2, 127.6, 127.2, 84.0, 
83.6, 81.9, 81.5, 79.3, 79.1, 70.7, 66.3, 56.2, 56.1, 47.1, 46.7, 30.7, 29.9, 29.1, 28.5, 24.2, 23.6, 23.4, 
22.9; IR 2979 (w), 2933 (w), 2932 (w), 2931 (w), 2926 (w), 2911 (w), 2910 (w), 2909 (w), 2881 (w), 
2880 (w), 2879 (w), 1733 (w), 1696 (s), 1656 (w), 1655 (w), 1654 (w), 1571 (w), 1571 (w), 1570 (w), 
1554 (w), 1553 (w), 1512 (w), 1455 (w), 1455 (w), 1396 (s), 1364 (w), 1341 (w), 1281 (w), 1280 (w), 
1252 (w), 1251 (w), 1241 (w), 1240 (w), 1164 (m), 1163 (m), 1120 (w), 1096 (w), 1057 (w), 960 (w), 
929 (w), 905 (w), 813 (w); HRMS (ESI) calcd for C22H32NO3 [M
+] 358.2382; found 358.2374.  
tert-Butyl 2-(4-(benzyloxy)dec-2-yn-1-yl)pyrrolidine-1-carboxylate (10aj): was prepared from N-
Boc-4-pentenamine (9a) (74.5 mg, 0.400 mmol) and alkynyl bromide 6j (161 mg, 0.520 mmol). It was 
obtained as a pale yellow oil (104 mg, 0.251 mmol, 63% yield); Rf 0.54 (Hexane/EtOAc 5/1). The prod-
uct was obtained as a mixture of rotamers. In order to characterize it, it was subjected to deprotection of 
the amino group according to the general procedure. 
(4-(Benzyloxy)dec-2-yn-1-yl)pyrrolidine (10aj'): was obtained as a dark yellow oil (76.6 mg, 0.244 
mmol, 97% yield); 1H NMR (400 MHz, CDCl3) δ 7.41-7.30 (m, 4 H), 7.28 (m, 1 H), 4.77 (d, 1 H, J = 
  
11.8 Hz), 4.49 (d, 1 H, J = 11.8 Hz), 4.07 (tt, 1 H, J = 6.5, 1.8 Hz), 3.23 (ddd, 1 H, J = 13.1, 6.5, 6.5 
Hz), 3.03 (m, 1 H), 2.88 (ddd, 1 H, J = 10.3, 7.2, 7.2 Hz), 2.42 (dd, 2 H, J = 6.1, 1.8 Hz), 1.97-1.86 (m, 
2 H), 1.85-1.61 (m, 3 H), 1.56-1.37 (m, 3 H), 1.35-1.21 (m, 6 H), 0.87 (t, 3 H, J = 6.5 Hz); 13C NMR 
(101 MHz, CDCl3) δ 139.9, 128.3, 127.9, 127.6, 81.1, 77.0, 70.4, 69.0, 57.6, 46.3, 36.0, 31.8, 30.6, 29.0, 
25.4, 25.1, 24.8, 22.6, 14.1; IR 3395 (br w), 3032 (w), 2953 (s), 2928 (s), 2857 (s), 1737 (m), 1715 (w), 
1690 (m), 1679 (m), 1642 (m), 1543 (w), 1497 (w), 1456 (m), 1435 (w), 1385 (w), 1380 (w), 1337 (w), 
1313 (w), 1287 (w), 1286 (w), 1236 (w), 1209 (w), 1209 (w), 1169 (w), 1154 (w), 1154 (w), 1089 (s), 
1070 (s), 1029 (m), 919 (w), 912 (w), 822 (w); HRMS (ESI) calcd for C21H32NO
+ [M+H]+ 314.2478; 
found 314.2486. 
tert-Butyl 2-(non-2-yn-1-yl)-5-phenylpyrrolidine-1-carboxylate (10ba): was prepared from N-Boc 
amine 9b (105 mg, 0.402 mmol) and octynyl bromide (6a) (98.0 mg, 0.521 mmol). It was obtained as a 
pale yellow oil (110 mg, 0.298 mmol, 74% yield); Rf 0.60 (Hexane/EtOAc 5/1). The product was ob-
tained as a mixture of rotamers. In order to characterize it, it was subjected to deprotection of the amino 
group according to the general procedure. 
2-(Non-2-yn-1-yl)-5-phenylpyrrolidine (10ba'): was obtained as a dark yellow oil (76.6 mg, 0.244 
mmol, 97% yield; mixture of inseparable diastereoisomers, d.r. trans/cis 10/90).34 1H NMR (400 MHz, 
CDCl3) δ 7.40 (m, 2 H), 7.31 (m, 2 H), 7.23 (m, 2 H), 4.17 (dd, J = 7.4, 7.4 Hz), 3.36 (ddd, J = 13.2, 
6.1, 6.1 Hz), 2.45 (dddd, 1 H, J = 16.4, 5.8, 2.3, 2.3 Hz), 2.38 (m, 1 H), 2.20-2.11 (m, 3 H), 1.98 (m, 1 
H), 1.79-1.63 (m, 2 H), 1.48 (quint, 2 H, J = 7.0 Hz), 1.43-1.32 (m, 2 H), 1.33-1.22 (m, 4 H), 0.88 (t, J = 
7.0 Hz); 13C NMR (101 MHz, CDCl3) δ 144.7, 128.2, 126.7, 126.6, 81.7, 77.6, 62.7, 57.9, 34.2, 31.3, 
30.7, 29.0, 28.5, 26.0, 22.5, 18.7, 14.0; IR 3063 (w), 3028 (w), 2955 (m), 2924 (s), 2853 (s), 1738 (w), 
1603 (w), 1492 (w), 1458 (m), 1434 (w), 1400 (w), 1399 (w), 1377 (w), 1250 (w), 1109 (w), 1075 (w), 
1028 (w), 910 (s), 828 (w); HRMS (ESI) calcd for C19H28N
+ [M+H]+ 270.2216; found 270.2225. 
tert-Butyl 2-heptyl-5-(non-2-yn-1-yl)pyrrolidine-1-carboxylate (10ca): was prepared from N-Boc 
amine 9c (108 mg, 0.400 mmol) and octynyl bromide (6a) (98.3 mg, 0.520 mmol). It was obtained as a 
  
pale yellow oil (77.0 mg, 0.204 mmol, 51% yield); Rf 0.89 (Hexane/EtOAc 5/1). The product was ob-
tained as a mixture of rotamers. In order to characterize it, it was subjected to deprotection of the amino 
group according to the general procedure. 
2-Heptyl-5-(non-2-yn-1-yl)pyrrolidine (10ca'): was obtained as a dark yellow oil (52.3 mg, 0.188 
mmol, 94% yield; mixture of inseparable diastereoisomers, d.r. trans/cis > 3/97);35 1H NMR (400 MHz, 
CDCl3) δ 3.13 (dddd, 1 H,  J = 7.5, 6.0, 6.0, 6.0 Hz), 2.97 (dddd, J = 8.0, 6.5, 6.5, 6.5 Hz), 2.32 (m, 2 
H), 2.13 (tt, 2 H, J = 6.9, 2.3 Hz), 1.88-1.77 (m, 3 H), 1.53-1.42 (m, 5 H), 1.41-1.21 (m, 14 H), 0.91-
0.83 (m, 6 H); 13C NMR (101 MHz, CDCl3) δ 81.8, 77.3, 59.6, 57.7, 36.7, 31.8, 31.7, 31.4, 30.3, 29.5, 
29.0, 28.5, 27.4, 25.5, 22.6, 22.6, 18.7, 14.1, 14.0; IR 2957 (m), 2927 (m), 2856 (m), 2184 (w), 2183 
(w), 1464 (w), 1434 (w), 1433 (w), 1404 (w), 1403 (w), 1379 (w), 1127 (w), 1122 (w), 1100 (w), 1084 
(w), 991 (w), 990 (w), 962 (w), 909 (s), 879 (w).1032 (w), 965 (w), 954 (w), 943 (w), 911 (m), 882 (w), 
881 (w), 861 (w), 827 (m), 814 (w); HRMS (ESI) calcd for C19H36N
+ [M+H]+ 278.2842; found 
278.2846. 
tert-Butyl 2-(but-3-en-1-yl)-5-(non-2-yn-1-yl)pyrrolidine-1-carboxylate (10da): was prepared from 
N-Boc amine 9d (95.0 mg, 0.397 mmol) and octynyl bromide (6a) (98.0 mg, 0.521 mmol). It was ob-
tained as a pale yellow oil (83.4 mg, 0.240 mmol, 60% yield); Rf 0.58 (Hexane/EtOAc 5/1). The product 
was obtained as a mixture of rotamers. In order to characterize it, it was subjected to deprotection of the 
amino group according to the general procedure. 
2-(But-3-en-1-yl)-5-(non-2-yn-1-yl)pyrrolidine (10da'): was obtained as a dark yellow oil (59.1 mg, 
0.239 mmol, 99% yield; mixture of inseparable diastereoisomers, d.r. trans/cis 5/95);36 1H NMR (400 
MHz, CDCl3) δ 5.81 (m, 1 H), 5.00 (dddd, 1 H, J = 17.1, 6.5, 2.0, 2.0 Hz), 4.92 (m, 1 H), 3.14 (ddd, 1 
H, J = 18.6, 6.0, 6.0 Hz), 3.00 (ddd, 1 H, J = 19.6, 5.5, 5.5 Hz), 2.35 (dddd, 1 H, J = 16.1, 8.0, 2.5, 2.5 
Hz), 2.27 (m, 1 H), 2.18-2.03 (m, 4 H), 1.96 (br s, 1 H), 1.90-1.76 (m, 2 H), 1.59 (dddd, 1 H, J = 13.6, 
8.5, 7.0, 7.0 Hz), 1.55-1.40 (m, 4 H), 1.40-1.20 (m, 7 H), 0.86 (t, 3 H, J = 6.2 Hz); 13C NMR (101 MHz, 
CDCl3) δ 138.6, 114.3, 81.7, 77.3, 58.9, 57.7, 35.7, 31.6, 31.5, 31.3, 30.2, 29.0, 28.5, 25.6, 22.5, 18.7, 
  
14.0; IR 3076 (w), 2956 (m), 2928 (s), 2857 (m), 1714 (w), 1698 (w), 1682 (w), 1661 (w), 1641 (w), 
1457 (w), 1435 (w), 1406 (w), 1379 (w), 1278 (w), 1177 (w), 1135 (w), 1115 (w), 995 (w), 910 (s); 
HRMS (ESI) calcd for C17H30N
+ [M+H]+ 248.2373; found 248.2371. 
tert-Butyl 2-(non-2-yn-1-yl)hexahydrocyclopenta[b]pyrrole-1(2H)-carboxylate (10ea): was pre-
pared from N-Boc amine 9e (90.1 mg, 0.400 mmol) and octynyl bromide (6a) (98.0 mg, 0.521 mmol). It 
was obtained as a pale yellow oil (98.5 mg, 0.295 mmol, 74% yield); Rf 0.55 (Hexane/EtOAc 5/1). The 
product was obtained as a mixture of rotamers. In order to characterize it, it was subjected to deprotec-
tion of the amino group according to the general procedure. 
2-(Non-2-yn-1-yl)octahydrocyclopenta[b]pyrrole (10ea'): was obtained as a dark yellow oil  (61.2 
mg, 0.263 mmol, 89% yield; mixture of inseparable diastereoisomers, d.r. trans/cis > 5/95); 1H NMR 
(400 MHz, CDCl3) δ 3.62 (dd, 1 H, J = 7.1, 7.1 Hz), 2.98 (ddd, 1 H, J = 16.2, 5.4, 5.4 Hz), 2.54 (dddd, J 
= 17.1, 8.0, 8.0, 2.5 Hz), 2.38 (dddd, 1 H, J = 16.4, 5.0, 2.4, 2.4 Hz), 2.28 (dddd, 1 H, J = 16.4, 4.9, 2.3, 
2.3 Hz), 2.13 (tt, 2 H, J = 6.9, 2.3 Hz), 2.05 (ddd, 1 H, J = 12.2, 8.9, 5.2 Hz), 1.86 (br s, 1 H), 1.68-1.48 
(m, 6 H), 1.46 (quint, 2 H, J = 7.0 Hz), 1.36 (dt, 2 H, J = 16.1, 7.0 Hz), 1.31-1.21 (m, 6 H), 1.01 (ddd, 1 
H, J = 11.8, 10.8, 8.9 Hz), 0.88 (t, 3 H, J = 6.7 Hz); 13C NMR (101 MHz, CDCl3) δ 82.0, 77.0, 63.5, 
58.8, 43.1, 39.8, 34.2, 33.1, 31.3, 29.0, 28.6, 24.1, 23.7, 22.5, 18.7, 14.0; IR 3344 (br w), 2951 (s), 2950 
(s), 2930 (s), 2858 (s), 1696 (w), 1695 (w), 1694 (w), 1693 (w), 1692 (w), 1689 (w), 1683 (w), 1682 
(w), 1641 (w), 1640 (w), 1465 (m), 1451 (m), 1434 (m), 1402 (w), 1379 (w), 1359 (w), 1348 (w), 1326 
(w), 1298 (w), 1286 (w), 1277 (w), 1221 (w), 1179 (w), 1165 (w), 1126 (w), 1112 (w), 1091 (w), 1072 
(w), 1046 (w), 1045 (w), 993 (w), 977 (w), 931 (w), 930 (w), 909 (m), 891 (w), 890 (w), 840 (w); 
HRMS (ESI) calcd for C16H28N
+ [M+H]+ 234.2216; found 234.2218. 
tert-Butyl 2-(non-2-yn-1-yl)octahydro-1H-indole-1-carboxylate (10fa): was prepared from N-Boc 
amine 9f (96.0 mg, 0.401 mmol) and octynyl bromide (6a) (98.0 mg, 0.521 mmol). It was obtained as a 
pale yellow oil (88.3 mg, 0.254 mmol, 64% yield); Rf 0.60 (Hexane/EtOAc 5/1). The product was ob-
  
tained as a mixture of rotamers. In order to characterize it, it was subjected to deprotection of the amino 
group according to the general procedure. 
2-(Non-2-yn-1-yl)octahydro-1H-indole (10fa'): was obtained as a yellow oil (61.7 mg, 0.249 mmol, 
98% yield; mixture of inseparable diastereoisomers, d.r. trans/cis 6/94);37 1H NMR (400 MHz, CDCl3) δ 
3.25 (dddd, 1 H, J = 8.0, 8.0, 6.0, 6.0 Hz), 3.05 (dd, 1 H, J = 10.8, 5.4 Hz), 2.43 (dddd, 1 H, J = 16.1, 
5.0, 2.5, 2.5 Hz), 2.37 (dddd, 1 H, J = 16.1, 4.5, 2.0, 2.0 Hz), 2.16 (tt, 2 H, J = 6.9, 2.3 Hz), 2.04 (m, 1 
H), 1.93 (m, 1 H), 1.78 (s, 1 H), 1.65 (m, 2 H), 1.57-1.42 (m, 6 H), 1.42-1.20 (m, 9 H), 0.88 (t, 3 H, J = 
6.8 Hz); 13C NMR (101 MHz, CDCl3) δ 81.8, 77.5, 57.8, 56.9, 38.3, 36.6, 31.3, 29.1, 29.0, 28.6, 28.6, 
26.3, 23.9, 22.5, 22.0, 18.8, 14.0.; IR 2926 (s), 2854 (m), 1451 (w), 1403 (w), 1377 (w), 1377 (w), 1347 
(w), 1347 (w), 1332 (w), 1332 (w), 1285 (w), 1285 (w), 1284 (w), 1284 (w), 1216 (w), 1083 (w), 1083 
(w), 1028 (w), 1028 (w), 910 (w), 818 (w).; HRMS (ESI) calcd for C17H30N
+ [M+H]+ 248.2373; found 
248.2369. 
tert-Butyl 2-(10-bromodec-2-yn-1-yl)octahydro-1H-indole-1-carboxylate (10fi): was prepared 
from N-Boc amine 9f (96.0 mg, 0.401 mmol) and alkynyl bromide 6i (147 mg, 0.520 mmol). It was 
obtained as a pale yellow oil (112 mg, 0.253 mmol, 63% yield, mixture of inseparable diastereoisomers, 
d.r. trans/cis < 5/95); Rf 0.69 (Hexane/EtOAc 5/1). The product was obtained as a mixture of rotamers. 
In order to characterize it, NMR spectra were acquired at 55 °C: 1H NMR (400 MHz, CDCl3) δ 3.83-
3.68 (m, 2 H), 3.39 (t, J = 6.8 Hz), 2.76 (m, 1 H), 2.46 (dddd, J = 16.1, 7.7, 2.3, 2.3 Hz), 2.25-2.10 (m, 3 
H), 2.03-1.91 (m, 3 H), 1.87 (quint, 2 H, J = 6.9 Hz), 1.73 (m, 1 H), 1.69-1.58 (m, 3 H), 1.56-1.24 (m, 
13 H), 1.46 (s, 9 H), 1.17 (tt, 1 H, J = 13.1, 3.0 Hz); 13C NMR (101 MHz, CDCl3) δ 154.5, 81.9, 78.9, 
77.5, 58.1, 57.0, 36.0, 33.8, 33.3, 32.9, 29.2, 28.9, 28.6, 28.3, 28.1, 26.3, 25.7, 25.3, 24.2, 20.9, 18.8; IR 
2929 (m), 2856 (w), 1690 (s), 1454 (w), 1394 (s), 1363 (m), 1295 (w), 1251 (w), 1164 (m), 1116 (m), 
1096 (w), 971 (w), 907 (w), 863 (w), 862 (w); HRMS (ESI) calcd for C23
79BrH39NO2
+ [M+H]+ 
440.2159; found 440.2166. 
  
tert-Butyl 2-(non-2-yn-1-yl)octahydrocyclohepta[b]pyrrole-1(2H)-carboxylate (10ga): was pre-
pared from N-Boc amine 9g (101 mg, 0.399 mmol) and octynyl bromide (6a) (98.0 mg, 0.521 mmol). It 
was obtained as a pale yellow oil (82.3 mg, 0.227 mmol, 57% yield); Rf 0.60 (Hexane/EtOAc 5/1). The 
product was obtained as a mixture of rotamers. In order to characterize it, it was subjected to deprotec-
tion of the amino group according to the general procedure. 
2-(Non-2-yn-1-yl)decahydrocyclohepta[b]pyrrole (10ga'): was obtained as a dark yellow oil  (53.4 
mg, 0.204 mmol, 90% yield; mixture of inseparable diastereoisomers, d.r. trans/cis > 10/90);38 1H NMR 
(400 MHz, CDCl3) δ 4.86 (br s, 1 H), 3.41 (ddd, 1 H, J = 11.6, 9.5, 4.0 Hz), 3.20 (ddd, J = 11.4, 11.4, 
6.0 Hz), 2.42 (dt, 2 H, J = 5.9, 2.4 Hz), 2.33 (m, 1 H), 2.15 (m, 1 H), 2.11 (tt, J = 6.7, 2.2 Hz, 2 H), 1.89 
(m, 1 H), 1.84-1.75 (m, 2 H), 1.63 (m, 1 H), 1.55 (dd, 1 H, J = 23.1, 11.1 Hz), 1.45 (m, 2 H), 1.39-1.11 
(m, 11 H), 0.87 (t, 3 H, J = 6.8 Hz); 13C NMR (101 MHz, CDCl3) δ 82.6, 75.8, 63.0, 57.9, 42.8, 39.7, 
31.5, 31.4, 31.3, 31.1, 29.2, 28.9, 28.5, 26.4, 23.2, 22.5, 18.7, 14.0; IR 2921 (m), 2854 (w), 2853 (w), 
2246 (w), 1680 (m), 1457 (w), 1445 (w), 1431 (w), 1430 (w), 1380 (w), 1202 (m), 1183 (m), 1182 (m), 
1139 (m), 1036 (w), 1028 (w), 1016 (w), 1008 (w), 998 (w), 909 (s), 835 (w); HRMS (ESI) calcd for 
C18H32N
+ [M+H]+ 262.2529; found 262.2519. 
tert-Butyl 2-(non-2-yn-1-yl)indoline-1-carboxylate (10ha): was prepared from N-Boc aniline 9h 
(93.3 mg, 0.400 mmol) and octynyl bromide (6a) (98.0 mg, 0.521 mmol). It was obtained as a pale yel-
low oil (109 mg, 0.319 mmol, 80% yield); Rf 0.55 (Hexane/EtOAc 5/1). The product was obtained as a 
mixture of rotamers. In order to characterize it, it was subjected to deprotection of the amino group ac-
cording to the general procedure. 
2-(Non-2-yn-1-yl)indoline (10ha'): was obtained as an orange oil (74.7 mg, 0.309 mmol, 90% yield); 
1H NMR (400 MHz, CDCl3) δ 7.07 (d, 1 H, J = 7.3 Hz), 7.01 (td, 1 H, J = 7.6, 0.5 Hz), 6.69 (m, 1 H), 
6.62 (d, 1 H, J = 7.8 Hz), 4.10 (br s, 1 H), 3.95 (ddd, 1 H, J = 13.4, 8.6, 6.2 Hz), 3.17 (dd, 1 H, J = 15.7, 
8.7 Hz), 2.75 (dd, 1 H, J = 15.7, 6.1 Hz), 2.38 (dd, 1 H, J = 4.8, 2.4 Hz), 2.35 (dd, 1 H, J = 3.8, 2.4 Hz), 
2.16 (tt, 2 H, J = 6.9, 2.3 Hz), 1.49 (quint, 2 H), 1.44-1.20 (m, 6 H), 0.90 (t, 3 H, J = 6.7 Hz); 13C NMR 
  
(101 MHz, CDCl3) δ 150.2, 128.0, 127.3, 124.8, 118.6, 109.2, 82.2, 77.0, 58.6, 35.5, 31.3, 28.9, 28.5, 
26.3, 22.5, 18.7, 14.0; IR 3372 (w), 2954 (w), 2929 (m), 2856 (w), 1731 (w), 1692 (m), 1610 (m), 1591 
(w), 1514 (m), 1485 (m), 1466 (m), 1455 (m), 1411 (w), 1366 (w), 1322 (w), 1301 (w), 1245 (s), 1158 
(s), 1119 (w), 1049 (w), 1023 (w), 918 (w), 898 (w), 879 (w), 842 (w); HRMS (ESI) calcd for C17H24N
+ 
[M+H]+ 242.1903; found 242.1901. 
2-(Non-2-yn-1-yl)-1-phenylpyrrolidine (10ia): was prepared from N-phenyl amine 9i (64.5 mg, 
0.400 mmol) and octynyl bromide (6a) (97.8 mg, 0.520 mmol). It was obtained as a pale yellow oil 
(85.3 mg, 0.317 mmol, 79% yield). Rf 0.55 (Hexane/EtOAc 10/1); 
1H NMR (400 MHz, CDCl3) δ 7.21 
(dd, 2 H, J = 8.4, 7.4 Hz), 6.67 (t, 1 H, J = 7.3 Hz), 6.60 (d, 2 H, J = 8.1 Hz), 3.86 (m, 1 H), 3.43 (m, 1 
H), 3.17 (m, 1 H), 2.58 (dd, 1 H, J = 16.4, 2.3 Hz), 2.17 (tt, 2 H, J = 6.9, 2.3 Hz), 2.14-1.95 (m, 5 H), 
1.49 (q, 2 H, J = 6.8 Hz), 1.40 (m, 2 H), 1.35-1.24 (m, 4 H), 0.90 (t, 3 H, J = 6.7 Hz); 13C NMR (101 
MHz, CDCl3) δ 146.8, 129.2, 115.6, 111.8, 81.9, 77.6, 58.3, 48.3, 31.4, 30.3, 29.0, 28.6, 23.0, 22.9, 
22.6, 18.8, 14.1; IR 2955 (m), 2930 (s), 2929 (s), 2856 (m), 1699 (w), 1599 (s), 1505 (s), 1483 (w), 
1482 (w), 1463 (w), 1366 (s), 1347 (m), 1346 (m), 1296 (w), 1244 (w), 1216 (w), 1215 (w), 1179 (w), 
1178 (w), 1161 (w), 1036 (w), 1036 (w), 994 (w), 958 (w), 958 (w), 911 (w), 858 (w); HRMS (ESI) 
calcd for C19H28N
+ [M+H]+ 270.2216; found 270.2222. 
1-(4-Methoxyphenyl)-2-(non-2-yn-1-yl)pyrrolidine (10ja): was prepared from N-para- methoxy-
phenyl amine 9j (76.5 mg, 0.400 mmol) and octynyl bromide (6a) (97.8 mg, 0.520 mmol). It was ob-
tained as a yellow oil (71.0 mg, 0.237 mmol, 59% yield). Rf 0.79 (Hexane/EtOAc 5/1); 
1H NMR (400 
MHz, CDCl3) δ 6.85 (m, 2 H), 6.56 (m, 2 H), 3.83-3.74 (m, 1 H), 3.76 (d, 2 H, J = 1.6 Hz), 3.41 (m, 1 
H), 3.12 (m, 1 H), 2.55 (ddd, 1 H, J = 16.5, 2.3, 2.3 Hz), 2.17 (m, 2 H), 2.13-1.95 (m, 5 H), 1.52 (m, 2 
H), 1.46-1.24 (m, 6 H), 0.91 (t, 3 H, J = 6.8 Hz); 13C NMR (101 MHz, CDCl3) δ 150.9, 141.8, 115.1, 
112.6, 81.8, 77.7, 58.8, 56.0, 49.0, 31.4, 30.4, 29.0, 28.6, 23.2, 22.6, 18.8, 14.1; IR 3045 (w), 2952 (m), 
2930 (m), 2857 (w), 2834 (w), 1622 (w), 1574 (w), 1515 (s), 1485 (w), 1463 (w), 1365 (w), 1340 (w), 
  
1329 (w), 1284 (w), 1242 (s), 1179 (w), 1044 (m), 980 (w), 961 (w), 960 (w), 911 (w), 888 (w), 813 
(m); HRMS (ESI) calcd for C20H30NO
+ [M+H]+ 300.2322; found 300.2319. 
General procedure for the oxy- and aminoalkynylation/in situ complete hydrogenation:  
Under inert atmosphere, Pd(dba)2 (11.5 mg, 0.0200 mmol, 0.05 equiv), DPEPHos (16.1 mg, 0.0300 
mmol, 0.075 equiv) and NaOtBu (50.0 mg, 0.520 mmol, 1.3 equiv) were introduced into a 5 mL vial, 
which was then sealed. Toluene was added (4.6 mL), followed by the bromo acetylene 6 (0.520 mmol, 
1.3 equiv) and the starting material 5 or 9 (0.40 mmol, 1.0 equiv). The mixture was stirred at 80 °C for 3 
h and then allowed to cool to rt. Toluene was removed under reduced pressure and MeOH was added 
(2.5-3.0 mL) followed by palladium on charcoal (two portions of ca. 50 mg). The mixture was purged 
with H2 over 10 minutes and stirred under a H2-atmosphere for 24 hours. Upon filtration through celite, 
the solvent was removed in vacuo and the crude mixture was then directly purified by column chroma-
tography (SiO2, pentane/EtOAc 98/2 to 96/4). 
2-Nonyltetrahydrofuran (11aa): was prepared from 4- penten-1-ol (5a) (34.4 mg, 0.400 mmol) and 
octynyl bromide (6a) (98.3 mg, 0.520 mmol). It was obtained as a pale yellow oil (40.0 mg, 0.202 
mmol, 51% yield). Rf 0.83 (Hexane/EtOAc 5/1); 
1H NMR (400 MHz, CDCl3) δ 3.85 (ddd, 1 H, J = 8.5, 
7.0, 6.0 Hz), 3.77 (ddd,1 H, J = 14.6, 7.0, 6.0 Hz), 3.70 (ddd, 1 H, J = 7.5, 7.5, 6.0 Hz), 1.95 (m, 1 H), 
1.91-1.79 (m, 2 H), 1.56 (m, 1 H), 1.48-1.20 (m, 14 H), 1.47-1.38 (m, 2 H), 0.87 (t, 3 H, J = 6.6 Hz); 13C 
NMR (101 MHz, CDCl3) δ 79.5, 67.6, 35.7, 31.9, 31.4, 29.8, 29.6, 29.6, 29.3, 26.4, 25.7, 22.7, 14.1; IR 
2957 (m), 2923 (s), 2872 (m), 2854 (s), 1489 (w), 1465 (w), 1379 (w), 1189 (w), 1180 (w), 1179 (w), 
1178 (w), 1177 (w), 1174 (w), 1173 (w), 1070 (m), 1039 (w), 1026 (w), 943 (w), 922 (w), 904 (w), 870 
(w), 861 (w), 850 (w); HRMS (ESI) calcd for C13H27O
+ [M+H]+ 199.2056; found 199.2056. 
tert-Butyl 2-nonylpyrrolidine-1-carboxylate (12aa): was prepared from N-Boc-4-pentenamine (9a) 
(74.5 mg, 0.400 mmol) and octynyl bromide (6a) (98.3 mg, 0.520 mmol). It was obtained as a pale yel-
low oil (87.1 mg, 0.293 mmol, 73% yield); Rf 0.83 (Hexane/EtOAc 5/1). The product was obtained as a 
  
mixture of rotamers. In order to characterize it, it was subjected to deprotection of the amino group ac-
cording to the general procedure. 
2-Nonylpyrrolidine (12aa'): was obtained as a yellow oil (61.1 mg, 0.310 mmol, quantitative); 1H 
NMR (400 MHz, CDCl3) δ 4.98 (br s, 1 H), 3.13-3.04 (m, 2 H), 2.94 (ddd, 1 H, J = 10.9, 8.3, 6.4 Hz), 
1.95 (m, 1 H), 1.89-1.72 (m, 2 H), 1.58 (m, 1 H), 1.50-1.40 (m, 1 H), 1.39-1.20 (m, 15 H,), 0.86 (t, 3 H, 
J = 6.6 Hz); 13C NMR (101 MHz, CDCl3) δ 59.7, 45.7, 34.9, 31.9, 31.3, 29.6, 29.5, 29.5, 29.3, 27.2, 
24.7, 22.6, 14.1; IR 3424 (w), 2957 (m), 2924 (s), 2873 (w), 2854 (s), 1678 (s), 1525 (w), 1524 (w), 
1460 (m), 1414 (m), 1379 (w), 1344 (w), 1201 (s), 1176 (s), 1133 (s), 1047 (w), 1036 (w), 1026 (w), 
937 (w), 930 (w), 929 (w), 909 (w), 908 (w), 899 (w), 831 (m), 815 (w); HRMS (ESI) calcd for 
C13H28N
+ [M+H]+ 198.2216; found 198.2219. 
[Pd(allyl)(cod)](BF4)2  
 
Following a reported procedure,39 [Pd(allyl)Cl]2 (300 mg, 0.820 mmol, 1.0 equiv) and AgBF4 (314 mg, 
1.61 mmol, 2.0 equiv) were introduced into a 2-necked flask under N2. CH2Cl2 (8.0 mL) was then added 
and the solution stirred at room temperature for 15 minutes. cod (0.33 mL, 1.6 mmol, 2.0 equiv) was 
then added and the solution was stirred for 1 h. Upon removal of the formed precipitate by filtration 
through celite, the resulting solution was treated with Et2O (50 mL) in order to induce the precipitation 
of the product. The latter was removed by filtration and washed with Et2O (3 x 10 mL) and dried in 
vacuo. The solid was taken up in CH2Cl2 and passed through a cotton wool plug; Et2O (2 x 15 mL) was 
again added to precipitate out the product, which was dried in vacuo. Complex [Pd(allyl)(cod)](BF4)2  
was finally obtained as a colorless solid (354 mg,1.04 mmol, 63% yield). 1H NMR (400 MHz, CDCl3) δ 
6.28 (broad d, 4 H), 6.10 (tt, J = 13.4, 7.3 Hz, 1 H), 4.98, (d, J = 7.3 Hz, 2 H), 3.98 (d, J = 13.4 Hz, 2 
H), 2.75-2.55 (m, 6 H), 2.36 (m, 2 H); 13C NMR (101 MHz, CDCl3) δ 125.6, 114.0, 112.9, 29.4.The 
values for the characterization correspond to the ones reported in literature.40 
  
[(Cinnamyl)PdCp] 
 
 Following a slightly modified version of a reported procedure,10 [Pd(cinnamyl)Cl]2 (300 mg, 
0.579 mmol, 1.0 equiv) was dissolved in THF (10 mL) and the solution was cooled to -78 °C. A solu-
tion prepared by diluting NaCp (2.0 M, 0.72 mL, 1.4 mmol, 2.5 equiv) with THF (10 mL) was then add-
ed dropwise and the resulting purple mixture was stirred at -78 °C for 5 min. It was then allowed to 
warm to rt and subsequently cooled to 0 °C. The solvent was removed from the cooled solution under 
reduced pressure and hexane (10 mL) was added. The dissolved solids were filtered off and the filtrate 
was concentrated in vacuo to obtain an oily purple solid. Upon addition of hexane (1.5 mL), crystalliza-
tion at -40 °C afforded [(Cinnamyl)PdCp] (317 mg, 0.550 mmol, 95% yield) as a dark-purple crystalline 
solid. 
1H NMR (400 MHz, C7D8) δ 7.28-7.22 (m, 2 H), 7.04-6.96 (m, 3 H), 5.63 (s, 5 H), 5.14 (ddd, 1 H, J = 
10.3, 10.3, 6.2 Hz), 3.84 (d, 1 H, J = 9.8 Hz), 3.36 (d, 1 H, J = 6.1 Hz), 2.16 (d, 1 H, J = 10.5 Hz). The 
values for the characterization of [(Cinnamyl)PdCp] correspond to the ones reported in literature.10 
Large scale reaction for the synthesis of 7bh 
 
  
Under inert atmosphere, Pd(dba)2 (53.2 mg, 0.0925 mmol, 0.05 equiv), DPEPHos (74.9 mg, 0.139 
mmol, 0.075 equiv) and NaOtBu (232 mg, 2.41 mmol, 1.3 equiv) were introduced into a 50 mL one-
neck flask. Toluene (21.3 mL) was added under an argon atmosphere, followed by the bromo acetylene 
6h (610 mg, 2.41 mmol, 1.3 equiv) and alcohol 5b (300 mg, 1.85 mmol, 1.0 equiv). The mixture was 
stirred at 80 °C for 3 h and then allowed to cool to room temperature. The solvent was evaporated under 
reduced pressure. The crude mixture was then directly purified by column chromatography (SiO2, pen-
tane/EtOAc 99/1). Fractions containing the inseparable mixture of alkyne 15 and dimer 16 were collect-
ed and purified again (SiO2, 98/2 pentane/Et2O). The isolation and identification showed that 13% of 5b 
(39.5 mg, 0.243 mmol) was recovered, 55% of 7bh (338 mg, 1.01 mmol) was formed and the following 
side-products were generated: ketone 13 (12.8 mg, 0.0799 mmol, 4%), hydroxy ketone 14 (40.9 mg, 
0.230 mmol, 12%), alkyne 15 (21.9 mg, 0.126 mmol, 5%) and dimer 16 (152 mg, 0.438 mmol, 36%).  
1-Phenylpent-4-en-1-one (13): Rf 0.37 (Pentane/EtOAc 20/1); 
1H NMR (400 MHz, CDCl3) δ 7.96 (m, 
2 H), 7.56 (m, 1 H), 7.46 (m, 2 H), 5.91 (m, 1 H), 5.09 (dd, 1 H, J = 17.1, 1.5 Hz), 5.01 (d, 1 H, J = 10.2 
Hz), 3.07 (ddd, 2 H, J = 7.3, 7.3, 2.0 Hz), 2.50 (m, 2 H); 13C NMR (101 MHz, CDCl3) δ 199.4, 137.3, 
136.9, 133.0, 128.6, 128.0, 115.2, 37.7, 28.1. The data for the characterization of compound 13 corre-
spond to the ones reported in the literature.41 
5-hydroxy-5-phenylpentan-2-one (14): Rf 0.05 (Pentane/EtOAc 20/1); 
1H NMR (400 MHz, CDCl3) δ 
7.37-7.30 (m, 3 H), 7.27 (m, 2 H), 4.72 (t, 1 H, J = 6.3 Hz), 2.55 (t, 2 H, J = 7.0 Hz), 2.13 (s, 3 H), 2.02 
(m, 2 H); 13C NMR (101 MHz, CDCl3) δ 209.1, 143.9, 128.2, 127.2, 125.4, 73.1, 39.5, 32.3, 29.7. The 
data for the characterization of compound 12 correspond to the ones reported in the literature.42 
(((2-methylbut-3-yn-2-yl)oxy)methyl)benzene (15): Rf 0.47 (Pentane/EtOAc 20/1); 
1H NMR (400 
MHz, CDCl3) δ 7.41-7.31 (m, 4 H), 7.27 (m, 1 H), 4.65 (s, 2 H), 2.49 (s, 1 H), 1.57 (s, 6 H); 13C NMR 
(101 MHz, CDCl3) δ 138.9, 128.3, 127.7, 127.3, 86.1, 72.2, 70.5, 66.5, 28.8. The data for the characteri-
zation of compound 13 correspond to the ones reported in the literature.43 
  
(((4-bromo-2-methylbut-3-yn-2-yl)oxy)methyl)benzene (16): Rf 0.40 (Pentane/EtOAc 20/1); Mp 
51.6-53.4 °C; 1H NMR (400 MHz, CDCl3) δ 7.37 (m, 8 H), 7.28 (m, 2 H), 4.65 (s, 4 H), 1.59 (s, 12 H); 
13C NMR (101 MHz, CDCl3) δ 138.6, 128.3, 127.7, 127.4, 81.7, 71.0, 68.5, 66.8, 28.7; IR 3091 (w), 
3067 (w), 3066 (w), 3063 (w), 3048 (w), 3033 (w), 2985 (m), 2934 (w), 2905 (w), 2865 (w), 2864 (w), 
2838 (w), 2374 (w), 2357 (w), 2150 (w), 1948 (w), 1871 (w), 1810 (w), 1745 (w), 1705 (w), 1606 (w), 
1517 (w), 1498 (w), 1464 (w), 1456 (m), 1438 (w), 1382 (m), 1360 (w), 1339 (w), 1330 (w), 1330 (w), 
1312 (w), 1303 (w), 1223 (m), 1185 (m), 1157 (s), 1122 (w), 1105 (w), 1086 (m), 1054 (s), 1030 (m), 
1003 (w), 941 (w), 925 (w), 912 (w), 883 (m), 847 (w), 828 (w), 821 (w); HRMS (ESI) calcd for 
C24H26NaO2 [M+Na] 369.1830; found 369.1836. 
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 1. General Methods 
All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, unless 
stated otherwise. For quantitative flash chromatography technical grade solvents were used. For 
flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were used. THF, 
Et2O, CH3CN, toluene, hexane and CH2Cl2 were dried by passage over activated alumina under 
nitrogen atmosphere (H2O content < 30 ppm, Karl-Fischer titration). All chemicals were 
commercially available and used as such unless stated otherwise. Chromatographic purification 
was performed as flash chromatography using silica 40-63, 60 Å, using the solvents indicated as 
eluent with 0.1-0.5 bar pressure (unprotected pyrrolidines were eluted using DCM/ULTRA; 
ULTRA; ULTRA: DCM/MeOH/(NH3 25% inwater) 75/25/5). TLC was performed on silica gel 
60 F254 TLC glass plates or aluminium plates and visualized with UV light, permanganate stain, 
CAN stain or Anisaldehyde stain. Melting points were measured on a melting point apparatus 
using open glass capillaries, the data is uncorrected. 1H-NMR spectra were recorded on a 400 
MHz spectrometer in chloroform-d, all signals are reported in ppm with the internal chloroform 
signal at 7.26 ppm. The data is being reported as (s = singlet, d = doublet, t = triplet, q = 
quadruplet, quint = quintet, m = multiplet or unresolved, br = broad signal, coupling constant(s) 
in Hz, integration; interpretation based on chemical shift, unless stated otherwise). 13C-NMR 
spectra were recorded with 1H-decoupling on a 100 MHz spectrometer in chloroform-d, DMSO-
d6, CD2Cl2 or CD3OD, all signals are reported in ppm with the internal chloroform signal at 77.0 
ppm. Infrared spectra were recorded on a FT-IR spectrophotometer with an ATR and a ZnSe 
prisma and are reported as cm-1 (w = weak, m = medium, s = strong, sh = shoulder, br = broad). 
Gas chromatographic and low resolution mass spectrometric measurements were performed 
using a fused silica column (length: 30 m, diameter: 0.32 mm) and Helium as carrier gas. High 
resolution mass spectrometric measurements were performed via Q-TOF API or ESI.  
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 2. Reaction Optimization 
GC-MS Quantification: 
A 0.0.30 M standard solution was prepared by dissolving pentadecane (0.100 mL, 0.364 mmol) 
in DCM (11.9 mL).  
2-(Non-2-yn-1-yl)tetrahydrofuran (7aa) (25.7 mg, 0.132 mmol) was dissolved in CH2Cl2 (ca. 
4.41 mL) (solution O).  
 0.50 mL of solution O were diluted by adding DCM (1.50 mL) to obtain solution A; 
 0.50 mL of solution O were mixed with 0.25 mL standard solution 0.030 M and 
diluted by adding CH2Cl2 (1.25 mL) to obtain solution B; 
 0.50 mL of solution O were mixed with 0.50 mL standard solution 0.030 M and 
diluted by adding CH2Cl2 (1.00 mL) to obtain solution C; 
 0.5 mL of solution O were mixed with 1.00 mL standard solution 0.025 M and 
diluted by adding CH2Cl2 (0.50 mL) to obtain solution D. 
GC-MS chromatograms were acquired for solutions A, B, C and D and in each of them the ratio 
between the integrals of the signals corresponding to the internal standard (retention time: 15.9 
min) and to the compound 7aa (retention time: 16.2 min) was calculated. These observed ratios 
by integration of the chromatogram peaks and the ratios (mmol pentadecane/mmol 7aa) were 
used as the axis of the calibration graph. 
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Entry  [Pd]-Catalyst Yield(%)
a 
1 Br Pd2(dba)3 44 
2 Br PdCl2(PPh3)2 31 
3 Br Pd(OAc)2 30 
4 Br (NHC)Pd(allyl)Cl (8)b 56 
5 Br (NHC)Pd(allyl)Cl (8)b -c 
6 Br [Pd(allyl)(cod)](BF4)2 50 
7 Br Pd(PPh3)4 33 
8 Br [Pd(cinnamyl)Cp] 50 
9 Br Pd(dba)2 51 
10 Cl Pd(dba)2 traces 
11 I Pd(dba)2 16 
(a) Conditions: 0.15 mmol 5a, 0.006 mmol [Pd] (4 mol %), 0.012 mmol DPE-Phos (8 mol 
%), 0.225 mmol 1-halooct-1-yne (1.5 equiv), 0.225 mmol NaOtBu (1.5 equiv), 0.8 mL 
toluene, 3 h, 75-80°C, yield was determined by GC-MS; (b) (NHC)Pd(allyl)Cl = Allyl[1,3-
bis(mesityl)imidazol-2-ylidene]palladium chloride; (c) no ligand added. 
Table S2. Screening of ligands and bases. 
 
Entry Base Ligand Yield(%)a 
1 NaOtBu DPE-Phos 51 
2 NaOtBu DPE-Phos  38b 
3 NaOtBu Xant-Phos  29 
4 NaOtBu dppf 16 
5 NaOtBu Seg-Phos  - 
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6 NaOtBu BINAP  - 
7 KOtBu DPE-Phos  traces 
8 LiOtBu DPE-Phos  traces 
9 NaHMDS DPE-Phos  24 
10 NaF DPE-Phos  - 
11 NaOAc DPE-Phos  - 
13 Na2CO3 DPE-Phos  - 
(a) Conditions: 0.15 mmol 5a, 0.006 mmol Pd(dba)2 (4 mol %), 0.012 mmol 
ligand (8 mol %), 0.225 mmol 6a (1.5 equiv), 0.225 mmol base (1.5 equiv), 0.8 
mL toluene, 3 h, 75-80°C, yield was determined by GC-MS; (b) 0.0060 mmol 
DPE-Phos (4 mol %). 
Table S3. Screening of additives 
Entry Pd complex Additive Yield(%)a 
1 Pd(dba)2 dba 55% 
2 [Pd(allyl)(cod)]BF4 dba 47% 
3 [Pd(allyl)(cod)]BF4 DCBA (83) 30% 
4 [Pd(allyl)(cod)]BF4 Phorone (84) 30% 
5 [Pd(allyl)(cod)]BF4 TPCPD (85) 15% 
6 [Pd(allyl)(cod)]BF4 Benzoquinone 32% 
7 [Pd(allyl)(cod)]BF4 Naphthoquinone 23% 
8 [Pd(allyl)(cod)]BF4 Tetrachlorobenzoquinone - 
9 [Pd(allyl)(cod)]BF4 cod 54% 
10 Pd(dba)2 15-Crown-5 48%b 
 
(a) Conditions: 0.15 mmol 5a, 0.006 mmol [Pd] (4 mol %), 0.012 mmol DPE-Phos (8 mol %), 
0.225 mmol 6a (1.5 equiv), 0.225 mmol base (1.5 equiv), 0.06 mmol additive (0.4 equiv), 0.8 
mL toluene, 3 h, 80°C, yield was determined by GC-MS; (b) 0.0060 mmol DPE-Phos (4 mol 
%); (b) 0.225 mmol 15-crown-5 (1.5 equiv). 
Table S4. Screening of solvents, concentrations and palladium sources 
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Entry Pd-catalyst Solvent Concentration Yield(%)a 
1 Pd(dba)2 THF 0.19 M 8 
2 Pd(dba)2 Dioxane 0.19 M - 
3 Pd(dba)2 CH3CN 0.19 M - 
4 Pd(dba)2 DMSO 0.19 M - 
5 Pd(dba)2 DCE 0.19 M - 
6 Pd(dba)2 Trifluoro toluene 0.19 M 32 
7 Pd(dba)2 Xylene 0.19 M 42 
8 Pd(dba)2 Toluene 0.50 M 35 
9 Pd(dba)2 Toluene 0.19 M 51 
10 Pd(dba)2 Toluene 0.075 M 65 
11 Pd(dba)2 Toluene 0.019 M 62 
12 Pd(dba)2 Toluene 0.19 M 61
b 
13 Pd(dba)2 Toluene 0.075 M 69c 
14 Pd(dba)2 Toluene 0.075 M 72c,d 
15 Pd2(dba)3 Toluene 0.075 M 47c 
16 Pd2(dba)3·CHCl3 Toluene 0.075 M 39c 
17 [Pd(cinnamyl)Cp] Toluene 0.075 M 51c 
(a) Conditions: 0.15 mmol 5a, 0.006 mmol [Pd] (4 mol %), 0.012 mmol DPE-Phos (8 mol %), 0.225 mmol 
6a (1.5 equiv), 0.225 mmol base (1.5 equiv), 0.06 mmol additive (0.4 equiv), 0.8 mL toluene, 3 h, 75-80°C, 
yield was determined by GC-MS; (b) 0.0060 mmol DPE-Phos (4 mol %); (b) 0.012 mmol Pd(dba)2 (8 mol 
%) and 0.024 mmol DPE-Phos (16 mol %); (c) 0.40 mmol 5a, 0.020 mmol [Pd] (5 mol %), 0.030 mmol 
ligand (7.5 mol %), 0.52 mmol 6a (1.3 equiv), 0.52 mmol NaOtBu (1.3 equiv), isolated yield determinded 
after column chromatography; (d) [Pd] 4 mol %, DPE-Phos16 mol %. 
3. Kinetic Datas: 
General procedure for standard conditions kinetic study: 
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Under inert atmosphere, Pd(dba)2 (7.90 mg, 0.0137 mmol, 0.05 equiv) and DPE-Phos (11.0 mg, 
0.0205 mmol, 0.075 equiv) were introduced into a 2 mL vial, then NatOBu (36.9 mg, 0.384 
mmol, 1.4 equiv) was introduced into another 2 mL vial and both vials were sealed. Degassed 
toluene was added into each vial (2 x 1.0 mL). To the catalyst mixture was added alkynyl 
bromide (6h) (97.2 mg, 0.384 mmol, 1.4 equiv) followed by degassed toluene (0.7 mL). To the 
base solution was added 1-phenylpent-4-en-1-ol (5b) (44.5 mg, 0.274 mmol, 1.0 equiv) and the 
internal standard (n-decane, 30 μL, 0.16 mmol) followed by degassed toluene (0.7 mL). The vials 
were stirred at 80 °C for 5 min and then the NatOBu-alcohol 5b solution was transferred via 
canula to the catalyst solution and samples were taken out at the indicated time and diluted with 
CH2Cl2 (1.0 mL). The obtained solutions were injected into the GC-MS chromatographer (the 
following oven program was used: Initial temperature: 50 °C, Ramp: 10.0 °C/min to 250 °C, hold 
25 min at 250 °C). Yields were determined by GC-MS, based on the following calibrations. 
GC-MS Quantification: 
A 0.775 M standard solution was prepared by dissolving n-decane (0.150 mL, 0.775 mmol) in 
CH2Cl2 (1.0 mL).  
1-Phenylpent-4-en-1-ol (5b) (22.2 mg, 0.137 mmol) was dissolved in CH2Cl2 (1.0 mL) (solution 
O).  
 25 µL of solution O were mixed with 100 µL of the standard solution 0.775 M and 
diluted by adding CH2Cl2 (600 µL) to obtain solution A; 
 33 µL of solution O were mixed with 100 µL of the standard solution 0.775 M and 
diluted by adding CH2Cl2 (600 µL) to obtain solution B; 
 50 µL of solution O were mixed with 100 µL of the standard solution 0.775 M and 
diluted by adding CH2Cl2 (600 µL) to obtain solution C; 
 75 µL of solution O were mixed with 100 µL of the standard solution 0.775 M and 
diluted by adding CH2Cl2 (600 µL) to obtain solution D; 
 100 µL of solution O were mixed with 100 µL of the standard solution 0.775 M and 
diluted by adding CH2Cl2 (600 µL) to obtain solution E; 
GC-MS chromatograms were acquired for solutions A, B, C, D and E and in each of them the 
ratio between the integrals of the signals corresponding to compound 5b (retention time: 14.0 
min) and to the internal standard (retention time: 8.50 min) was calculated. These observed ratios 
by integration of the chromatogram peaks and the ratios (mmol 5b/mmol n-decane) were used as 
the axis of the calibration graph. 
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Alkynyl bromide 6h (49.4 mg, 0.195 mmol) was dissolved in CH2Cl2 (1.0 mL) (solution P).  
 25 µL of solution P were mixed with 100 µL of the standard solution 0.775 M and 
diluted by adding CH2Cl2 (600 µL) to obtain solution A; 
 33 µL of solution P were mixed with 100 µL of the standard solution 0.775 M and 
diluted by adding CH2Cl2 (600 µL) to obtain solution B; 
 50 µL of solution P were mixed with 100 µL of the standard solution 0.775 M and 
diluted by adding CH2Cl2 (600 µL) to obtain solution C; 
 75 µL of solution P were mixed with 100 µL of the standard solution 0.775 M and 
diluted by adding CH2Cl2 (600 µL) to obtain solution D; 
 100 µL of solution P were mixed with 100 µL of the standard solution 0.775 M and 
diluted by adding CH2Cl2 (600 µL) to obtain solution E; 
GC-MS chromatograms were acquired for solutions A, B, C, D and E and in each of them the 
ratio between the integrals of the signals corresponding to compound 6h (retention time: 15.95 
min) and to the internal standard (retention time: 8.50 min) was calculated. These observed ratios 
by integration of the chromatogram peaks and the ratios (mmol 6h/mmol n-decane) were used as 
the axis of the calibration graph. 
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Oxyalkynylation product 7bh (45.8 mg, 0.137 mmol) was dissolved in CH2Cl2 (1.0 mL) (solution 
Q).  
 25 µL of solution Q were mixed with 100 µL of the standard solution 0.775 M and 
diluted by adding CH2Cl2 (600 µL) to obtain solution A; 
 33 µL of solution Q were mixed with 100 µL of the standard solution 0.775 M and 
diluted by adding CH2Cl2 (600 µL) to obtain solution B; 
 50 µL of solution Q were mixed with 100 µL of the standard solution 0.775 M and 
diluted by adding CH2Cl2 (600 µL) to obtain solution C; 
 75 µL of solution Q were mixed with 100 µL of the standard solution 0.775 M and 
diluted by adding CH2Cl2 (600 µL) to obtain solution D; 
 100 µL of solution Q were mixed with 100 µL of the standard solution 0.775 M and 
diluted by adding CH2Cl2 (600 µL) to obtain solution E; 
GC-MS chromatograms were acquired for solutions A, B, C, D and E and in each of them the 
ratio between the integrals of the signals corresponding to compound 7bh (retention time: 36.38 
min) and to the internal standard (retention time: 8.50 min) was calculated. These observed ratios 
by integration of the chromatogram peaks and the ratios (mmol 7bh/mmol n-decane) were used 
as the axis of the calibration graph. The data corresponding to solution A was discarded in order 
to get a better accuracy.  
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Stoichiometric Calculations for product 7bh formation: 
The reagent stoichiometry kinetic study was performed following the general procedure for the 
standard conditions with the amount of reagents described in table S5. The data for the reagent 
stoichiometry effect on the rate of formation of 7bh are shown in tables S6-S10. The 
concentrations (in mmol) for the formation of 7bh were calculated using the equation of the 
corresponding calibration curve (Calibration Curve for 7bh). The standard deviations were 
calculated using the following equation:  
𝑠 = √
1
𝑛
∑(𝑥𝑖−?̅?)
2
𝑛
𝑖=1
  , 𝑛 = 3 
Table S5: Reagent stoichiometry conditions. 
Entry 5b [mmol] 6h  [mmol] 
Pd(dba)2  
[mmol] 
DPE-Phos 
[mmol] 
NatOBu 
[mmol] 
1 0.547 0.384 0.0137 0.0205 0.384 
2 0.274 0.768 0.0137 0.0205 0.384 
3 0.274 0.384 0.0274 0.0410 0.384 
4 0.274 0.384 0.0137 0.0205 0.768 
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Table S6: Rate of formation of 7bh using conditions of Entry 1, Table S5. 
Time [min] 
Exp. 1 :mmol 
of 7bh 
Exp. 2 :mmol 
of 7bh 
Exp. 3 :mmol 
of 7bh 
Average: 
mmol of 7bh 
Standard 
Deviation 
0 0 0 0 0 0 
2 0.00592 0.00406 0.004622 0.00445 0.000278 
4 0.00870 0.0186 0.00554 0.00595 0.000306 
6 0.0119 0.00628 0.00763 0.00769 0.000221 
8 0.0148 0.00746 0.00860 0.00907 0.000716 
10 0.0171 0.00854 0.00930 0.00994 0.000452 
12 0.0210 0.0103 0.0130 0.0120 0.000914 
15 0.0227 0.0108 0.0126 0.0132 0.000629 
18 0.0251 0.0141 0.0136 0.0149 0.00105 
21 0.0327 0.0161 0.0147 0.0159 0.000827 
31 0.0366 0.0164 0.0166 0.0181 0.00148 
41 0.0416 0.0175 0.0168 0.0192 0.00221 
51 0.0505 0.0187 0.0170 0.0195 0.00186 
61 0.0557 0.0201 0.0167 0.0196 0.00300 
76 0.0553 0.0182 0.0173 0.0203 0.00332 
 
Table S7: Rate of formation of 7bh using conditions of Entry 2, Table S5. 
Time [min] 
Exp. 1 :mmol 
of 7bh 
Exp. 2 :mmol 
of 7bh 
Exp. 3 :mmol 
of 7bh 
Average: 
mmol of 7bh 
Standard 
Deviation 
0 0 0 0 0 0 
2 0.00420 0.00247 0.00395 0.00354 0.000761 
4 0.00568 0.00506 0.00631 0.00568 0.000511 
6 0.00816 0.00666 0.00822 0.00768 0.000721 
8 0.0103 0.00820 0.00977 0.00942 0.000886 
10 0.0121 0.0108 0.0108 0.0112 0.000600 
12 0.0133 0.0114 0.0121 0.0122 0.000819 
15 0.0161 0.0141 0.0132 0.0145 0.00122 
18 0.0167 0.0156 0.0147 0.0157 0.000827 
21 0.0196 0.0162 0.0162 0.0173 0.00161 
31 0.0247 0.0220 0.0190 0.0219 0.00232 
41 0.0328 0.0286 0.0218 0.0277 0.00453 
51 0.0348 0.0263 0.0240 0.0283 0.00465 
61 0.0393 0.0254 0.0215 0.0287 0.00763 
76 0.0371 0.0248 0.0211 0.0277 0.00683 
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Table S8: Rate of formation of 7bh using conditions of Entry 3, Table S5. 
Time [min] 
Exp. 1 :mmol 
of 7bh 
Exp. 2 :mmol 
of 7bh 
Exp. 3 :mmol 
of 7bh 
Average: 
mmol of 7bh 
Standard 
Deviation 
0 0 0 0 0 0 
2 0.00488 0.00844 0.00643 0.00658 0.00146 
4 0.00961 0.0124 0.0101 0.0107 0.00120 
6 0.0101 0.0168 0.0135 0.0135 0.00270 
8 0.0172 0.0237 0.0165 0.0191 0.00323 
10 0.0213 0.0255 0.0197 0.0221 0.00247 
12 0.0236 0.0289 0.0235 0.0254 0.00252 
15 0.0269 0.0377 0.0282 0.0309 0.00483 
18 0.0312 0.0438 0.0302 0.0351 0.00621 
21 0.0344 0.0438 0.0341 0.0374 0.00449 
31 0.0400 0.0458 0.0356 0.0405 0.00419 
41 0.0431 0.0487 0.0371 0.0430 0.00476 
51 0.0419 0.0459 0.0387 0.0421 0.00294 
61 0.0398 0.0526 0.0362 0.0429 0.00703 
76 0.0403 0.0443 0.0343 0.0396 0.00413 
 
Table S9: Rate of formation of 7bh using conditions of Entry 4, Table S5. 
Time [min] mmol of 7bh 
0 0 
2 0.00164 
4 0.00162 
6 0.00157 
8 0.00207 
10 0.00206 
12 0.00210 
15 0.00250 
18 0.00239 
21 0.00307 
31 0.00344 
41 0.00397 
51 0.00425 
61 0.00447 
76 0.00451 
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Table S10: Rate of formation of 7bh using the standard conditions described in the general procedure. 
Time [min] 
Exp. 1 :mmol 
of 7bh 
Exp. 2 :mmol 
of 7bh 
Exp. 3 :mmol 
of 7bh 
Average: 
mmol of 7bh 
Standard 
Deviation 
0 0 0 0 0 0 
2 0.00104 0.00249 0.00294 0.00216 0.000809 
4 0.00331 0.00376 0.00383 0.00363 0.000229 
6 0.00461 0.00588 0.00580 0.00543 0.000579 
8 0.00592 0.00684 0.00744 0.00673 0.000621 
10 0.00756 0.00822 0.00907 0.00828 0.000621 
12 0.00850 0.00999 0.0102 0.00957 0.000762 
15 0.0102 0.0113 0.0137 0.0117 0.00148 
18 0.0116 0.0133 0.0149 0.0133 0.00136 
21 0.0130 0.0165 0.0168 0.0154 0.00173 
31 0.0165 0.0217 0.0238 0.0207 0.00306 
41 0.0196 0.0259 0.0260 0.0238 0.00296 
51 0.0215 0.0287 0.0294 0.0265 0.00358 
61 0.0239 0.0286 0.0311 0.0279 0.00297 
76 0.0263 0.0304 0.0298 0.0288 0.00179 
 
Crude analysis of the initial rate of the product formation : 
The initial rate of the product formation was determined by a linear fitting of the four first points 
of tables S6, S7, S8 and S10. The slope of the linear regression gave the following initial rates: 
Table S11: Initial rate of formation of 7bh.  
 Table S6 Table S7 Table S8 Table S10 
Initial rate [𝒎𝒊𝒏−𝟏 ∙ 𝒄𝒊
𝟏−𝒏𝒊] 0.00141 0.00136 0.00244 0.000918 
 
Knowing the initial rates (Table S11) and the initial concentrations (Table S12) the orders were 
calculated using the following general equations and the van’t Hoff plot (log (initial rate) as a 
function of log (initial concentration)) by comparing the data of each reagent specie with the 
standard conditions: 
𝑣 = 𝑘 ∏ 𝑐𝑖
𝑛𝑖𝑟
𝑖=1    and   𝑛 ≔ ∑ 𝑛𝑖
𝑟
𝑖=1  = (overall) order of a reaction 
r = number of reactants, ci = concentration of reactant i 
Table S12: Initial concentrations and orders of the reagent species. 
Reagent 
Initial Concentration 
(Table 1) [mmol] 
Initial Concentration 
(standard conditions) 
[mmol] 
Order ni 
5b 0.547 0.274 0.6 
6h 0.768 0.384 0.6 
Pd(dba)2 0.0410 0.0205 1.4 
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In the case of the base, the initial rate was not determined as no linear fitting was possible due to 
the base mediated inhibition of the reaction.  
5. Spectra of New Compounds   
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Tetradec-1-en-7-yn-5-ol (5c) 
 
 
 
S16 
 
((5-Bromopent-4-yn-1-yl)oxy)(tert-butyl)diphenylsilane (6d) 
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1-Bromo-5-chloropent-1-yne (6f) 
 
 
 
S18 
 
(7-Bromohepta-1,6-diyn-1-yl)triisopropylsilane (6g) 
 
 
 
S19 
 
(((4-Bromo-2-methylbut-3-yn-2-yl)oxy)methyl)benzene (6h) 
 
 
 
S20 
 
((4-bromo-2-methylbut-3-yn-2-yl)oxy)triisopropylsilane (6i) 
 
 
 
S21 
 
(((1-Bromonon-1-yn-3-yl)oxy)methyl)benzene (6j) 
 
 
 
S22 
 
((1-Bromonon-1-yn-3-yl)oxy)triisopropylsilane (6k) 
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1,9-Dibromonon-1-yne (6l) 
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2-(Non-2-yn-1-yl)tetrahydrofuran (7aa) 
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tert-Butyldiphenyl((6-(tetrahydrofuran-2-yl)hex-4-yn-1-yl)oxy)silane (7ad) 
 
 
 
S26 
 
2-(6-Phenylhex-2-yn-1-yl)tetrahydrofuran (7ae) 
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2-(6-Chlorohex-2-yn-1-yl)tetrahydrofuran (7af) 
 
 
 
S28 
 
Triisopropyl(8-(tetrahydrofuran-2-yl)octa-1,6-diyn-1-yl)silane (7ag) 
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2-(4-(Benzyloxy)-4-methylpent-2-yn-1-yl)tetrahydrofuran (7ah) 
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Triisopropyl((2-methyl-5-(tetrahydrofuran-2-yl)pent-3-yn-2-yl)oxy)silane (7ai) 
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2-(4-(Benzyloxy)dec-2-yn-1-yl)tetrahydrofuran (7aj) 
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Triisopropyl((1-(tetrahydrofuran-2-yl)dec-2-yn-4-yl)oxy)silane (7ak) 
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2-(4-(Benzyloxy)-4-methylpent-2-yn-1-yl)-5-phenyltetrahydrofuran (7bh) 
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2,5-Di(non-2-yn-1-yl)tetrahydrofuran (7ca) 
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tert-Butyl undec-1-en-5-ylcarbamate (9c) 
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tert-Butyl (2-allylcyclopentyl)carbamate (9e)  
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tert-Butyl (2-allylcyclohexyl)carbamate (9f) 
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tert-Butyl (2-allylcycloheptyl)carbamate (9g) 
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2-(Non-2-yn-1-yl)pyrrolidine (10aa') 
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2-(6-((tert-Butyldiphenylsilyl)oxy)hex-2-yn-1-yl)pyrrolidine (10ad') 
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2-(6-Phenylhex-2-yn-1-yl)pyrrolidine (10ae') 
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tert-Butyl 2-(4-(benzyloxy)-4-methylpent-2-yn-1-yl)pyrrolidine-1-carboxylate (10ah) 
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(4-(Benzyloxy)dec-2-yn-1-yl)pyrrolidine (10aj') 
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2-(Non-2-yn-1-yl)-5-phenylpyrrolidine (10ba') 
 
 
 
S45 
 
2-Heptyl-5-(non-2-yn-1-yl)pyrrolidine (10ca') 
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2-(But-3-en-1-yl)-5-(non-2-yn-1-yl)pyrrolidine (10da') 
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2-(Non-2-yn-1-yl)octahydrocyclopenta[b]pyrrole (10ea') 
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2-(Non-2-yn-1-yl)octahydro-1H-indole (10fa') 
 
 
 
S49 
 
tert-Butyl 2-(10-bromodec-2-yn-1-yl)octahydro-1H-indole-1-carboxylate (10fl) 
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2-(Non-2-yn-1-yl)decahydrocyclohepta[b]pyrrole (10ga') 
 
 
 
S51 
 
2-(Non-2-yn-1-yl)indoline (10ha') 
 
 
 
S52 
 
2-(Non-2-yn-1-yl)-1-phenylpyrrolidine (10ia) 
 
 
 
S53 
 
1-(4-Methoxyphenyl)-2-(non-2-yn-1-yl)pyrrolidine (10ja) 
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2-Nonyltetrahydrofuran (11aa) 
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2-Nonylpyrrolidine (12aa')  
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(((2,7-dimethylocta-3,5-diyne-2,7-diyl)bis(oxy))bis(methylene))dibenzene (16) 
 
 
